| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 2.02e-05 | 6 | 203 | 3 | GO:0008510 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 9.07e-05 | 45 | 203 | 5 | GO:0043495 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | GBF1 TRIO DOCK11 DENND5A ARHGEF6 DOCK3 CCZ1B KALRN ARHGEF12 CCZ1 | 1.32e-04 | 231 | 203 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 2.75e-04 | 13 | 203 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 3.06e-04 | 3 | 203 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 3.06e-04 | 3 | 203 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | protein kinase activity | ATR TRIO CDK15 INSR SNRK NEK3 COQ8A CLK1 WNK2 KALRN MST1R IGF2R GUCY2C DCLK3 ATM MAPK7 | 4.39e-04 | 600 | 203 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.09e-04 | 4 | 203 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | GBF1 TRIO DOCK11 GIT2 FAM13B DENND5A ARHGEF6 DOCK3 CCZ1B KALRN GPS1 ARHGEF12 ARHGAP5 CCZ1 | 7.14e-04 | 507 | 203 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | GBF1 TRIO DOCK11 GIT2 FAM13B DENND5A ARHGEF6 DOCK3 CCZ1B KALRN GPS1 ARHGEF12 ARHGAP5 CCZ1 | 7.14e-04 | 507 | 203 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RNF112 PSMC3 RRAGB ARL5A ABCB1 KIF14 DHX35 HSPA5 DNAH3 KIF23 DDX60 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA FITM1 ATP4A | 9.58e-04 | 839 | 203 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RNF112 PSMC3 RRAGB ARL5A ABCB1 KIF14 DHX35 HSPA5 DNAH3 KIF23 DDX60 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA FITM1 ATP4A | 9.71e-04 | 840 | 203 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RNF112 PSMC3 RRAGB ARL5A ABCB1 KIF14 DHX35 HSPA5 DNAH3 KIF23 DDX60 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA FITM1 ATP4A | 9.71e-04 | 840 | 203 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RNF112 PSMC3 RRAGB ARL5A ABCB1 KIF14 DHX35 HSPA5 DNAH3 KIF23 DDX60 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA ATP4A | 9.81e-04 | 775 | 203 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.01e-03 | 5 | 203 | 2 | GO:0141003 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 4.58e-05 | 212 | 201 | 10 | GO:0000070 | |
| GeneOntologyBiologicalProcess | cell cycle process | NUSAP1 TPR SYCP2L ATR STAG1 RNF112 INSR ABCB1 FANCA FANCD2 KLHL13 KIF14 DSCC1 NIPBL USP47 KNL1 KIF23 USP28 CECR2 UFL1 XPO1 NR3C1 XRCC2 USP37 SMC2 CCNB1 TGFB1 LMNA CCNB3 ATM | 6.54e-05 | 1441 | 201 | 30 | GO:0022402 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | NUSAP1 TPR STAG1 INSR KIF14 NIPBL KNL1 KIF23 SMC2 CCNB1 TGFB1 ATM | 6.69e-05 | 316 | 201 | 12 | GO:0140014 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | ATR TSC1 AKAP6 KALRN VPS26B SYNE1 XPO1 ADAM22 LMNA ABCE1 ATM | 9.38e-05 | 278 | 201 | 11 | GO:0031503 |
| GeneOntologyBiologicalProcess | positive regulation of tubulin deacetylation | 9.45e-05 | 2 | 201 | 2 | GO:0090044 | |
| GeneOntologyBiologicalProcess | telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904868 | |
| GeneOntologyBiologicalProcess | positive regulation of telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904884 | |
| GeneOntologyBiologicalProcess | regulation of telomerase catalytic core complex assembly | 9.45e-05 | 2 | 201 | 2 | GO:1904882 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.03e-04 | 10 | 203 | 3 | GO:0014701 | |
| MousePheno | malocclusion | 1.78e-05 | 47 | 165 | 6 | MP:0000120 | |
| MousePheno | misaligned teeth | 3.21e-05 | 52 | 165 | 6 | MP:0030540 | |
| Domain | SPEC | 3.05e-08 | 32 | 193 | 7 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.05e-08 | 32 | 193 | 7 | IPR018159 | |
| Domain | Spectrin_repeat | 4.39e-07 | 29 | 193 | 6 | IPR002017 | |
| Domain | Spectrin | 3.24e-06 | 23 | 193 | 5 | PF00435 | |
| Domain | Na/HCO3_transpt | 1.07e-05 | 5 | 193 | 3 | IPR003024 | |
| Domain | - | 8.72e-05 | 9 | 193 | 3 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 8.72e-05 | 9 | 193 | 3 | IPR013769 | |
| Domain | Band_3_cyto | 8.72e-05 | 9 | 193 | 3 | PF07565 | |
| Domain | CRM1_C | 1.06e-04 | 2 | 193 | 2 | PF08767 | |
| Domain | NatA_aux_su | 1.06e-04 | 2 | 193 | 2 | IPR021183 | |
| Domain | DUF1712 | 1.06e-04 | 2 | 193 | 2 | PF08217 | |
| Domain | CRM1_C_dom | 1.06e-04 | 2 | 193 | 2 | IPR014877 | |
| Domain | NARP1 | 1.06e-04 | 2 | 193 | 2 | PF12569 | |
| Domain | DUF1712_fun | 1.06e-04 | 2 | 193 | 2 | IPR013176 | |
| Domain | PTrfase/Anion_transptr | 1.24e-04 | 10 | 193 | 3 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.24e-04 | 10 | 193 | 3 | IPR003020 | |
| Domain | HCO3_cotransp | 1.24e-04 | 10 | 193 | 3 | PF00955 | |
| Domain | HCO3_transpt_C | 1.24e-04 | 10 | 193 | 3 | IPR011531 | |
| Domain | Ryanodine_rcpt | 3.17e-04 | 3 | 193 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 3.17e-04 | 3 | 193 | 2 | IPR009460 | |
| Domain | RyR | 3.17e-04 | 3 | 193 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.17e-04 | 3 | 193 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.17e-04 | 3 | 193 | 2 | IPR013333 | |
| Domain | P-loop_NTPase | RNF112 PSMC3 RRAGB ARL5A ABCB1 SULT1E1 MPP4 KIF14 DHX35 SULT4A1 DNAH3 KIF23 DDX60 XRCC2 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA | 5.10e-04 | 848 | 193 | 20 | IPR027417 |
| Domain | Kinase-like_dom | ATR TRIO CDK15 INSR SNRK NEK3 COQ8A CLK1 WNK2 KALRN MST1R GUCY2C DCLK3 ATM MAPK7 | 5.28e-04 | 542 | 193 | 15 | IPR011009 |
| Domain | TSC-22_Dip_Bun | 6.29e-04 | 4 | 193 | 2 | IPR000580 | |
| Domain | TSC-22_Dip_Bun | 6.29e-04 | 4 | 193 | 2 | PD007152 | |
| Domain | Gtr1_RagA | 6.29e-04 | 4 | 193 | 2 | IPR006762 | |
| Domain | Gtr1_RagA | 6.29e-04 | 4 | 193 | 2 | PF04670 | |
| Domain | TSC22 | 6.29e-04 | 4 | 193 | 2 | PF01166 | |
| Domain | TSC22 | 6.29e-04 | 4 | 193 | 2 | PS01289 | |
| Domain | - | RNF112 PSMC3 RRAGB ARL5A ABCB1 SULT1E1 MPP4 DHX35 SULT4A1 DNAH3 DDX60 XRCC2 SMC2 ARHGAP5 ARL5B IQCA1 ABCE1 RRAGA | 7.53e-04 | 746 | 193 | 18 | 3.40.50.300 |
| Domain | ARM-type_fold | 8.28e-04 | 339 | 193 | 11 | IPR016024 | |
| Domain | FATC | 1.04e-03 | 5 | 193 | 2 | PF02260 | |
| Domain | RIH_assoc-dom | 1.55e-03 | 6 | 193 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.55e-03 | 6 | 193 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.55e-03 | 6 | 193 | 2 | PF08454 | |
| Domain | RIH_dom | 1.55e-03 | 6 | 193 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.55e-03 | 6 | 193 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.55e-03 | 6 | 193 | 2 | IPR015925 | |
| Domain | FAT | 1.55e-03 | 6 | 193 | 2 | PS51189 | |
| Domain | FATC | 1.55e-03 | 6 | 193 | 2 | PS51190 | |
| Domain | - | 1.55e-03 | 6 | 193 | 2 | 1.25.10.30 | |
| Domain | FAT | 1.55e-03 | 6 | 193 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.55e-03 | 6 | 193 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.55e-03 | 6 | 193 | 2 | IPR003152 | |
| Domain | RYDR_ITPR | 1.55e-03 | 6 | 193 | 2 | PF01365 | |
| Domain | PIK_FAT | 1.55e-03 | 6 | 193 | 2 | IPR014009 | |
| Domain | FATC | 1.55e-03 | 6 | 193 | 2 | SM01343 | |
| Domain | PROTEIN_KINASE_DOM | TRIO CDK15 INSR SNRK NEK3 COQ8A CLK1 WNK2 KALRN MST1R GUCY2C DCLK3 MAPK7 | 1.90e-03 | 493 | 193 | 13 | PS50011 |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 1.41e-06 | 9 | 148 | 4 | M47586 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 2.33e-06 | 10 | 148 | 4 | M47572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M | 3.85e-05 | 7 | 148 | 3 | M47574 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 6.11e-05 | 8 | 148 | 3 | M42528 | |
| Pathway | BIOCARTA_ATRBRCA_PATHWAY | 7.37e-05 | 22 | 148 | 4 | M9703 | |
| Pathway | PID_FANCONI_PATHWAY | 1.28e-04 | 47 | 148 | 5 | M1 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.29e-04 | 10 | 148 | 3 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 1.29e-04 | 10 | 148 | 3 | MM15073 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.40e-04 | 184 | 148 | 9 | M41809 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M | 1.76e-04 | 11 | 148 | 3 | M47573 | |
| Pathway | PID_BARD1_PATHWAY | 2.26e-04 | 29 | 148 | 4 | M258 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | NCKAP1 TRIO DOCK11 SPTAN1 GIT2 FAM13B KIF14 ARHGEF6 DOCK3 KALRN DSP GPS1 ARHGEF12 ARHGAP5 | 2.77e-04 | 450 | 148 | 14 | M27078 |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 3.00e-04 | 13 | 148 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 3.00e-04 | 13 | 148 | 3 | M27661 | |
| Pathway | PID_HDAC_CLASSII_PATHWAY | 4.23e-04 | 34 | 148 | 4 | M30 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR EPRS1 GBF1 ATR NCKAP1 TRIO SPTAN1 PSMC3 RPL10A FANCD2 TTLL12 CDC40 GCLC EIF3L KIF14 CC2D2A NIPBL HSPA5 KIF23 DSP NSD2 SYNE1 POR UFL1 COPS3 XPO1 SMC2 PRPF8 IGF2R LMNA USO1 ABCE1 ATM PCMT1 | 3.35e-12 | 1425 | 204 | 34 | 30948266 |
| Pubmed | TPR NCKAP1 TRIO DOCK11 SPTAN1 SPTBN2 TSC1 GIT2 BCOR CCDC13 NUFIP2 NIPBL WNK2 AMPD2 KIF23 SLC4A8 KALRN USP28 SYNE1 DLGAP4 HECTD4 ARHGEF12 SMC2 ARPC4 ADAM22 IGF2R DZIP3 SLC4A4 | 3.54e-12 | 963 | 204 | 28 | 28671696 | |
| Pubmed | TPR NCKAP1 SPTAN1 SPTBN2 PSMC3 RPL10A TTLL12 EIF3L NUFIP2 KIF14 NIPBL USP47 PNP KIF23 NAA15 DSP NSD2 XPO1 PRPF8 IGF2R LMNA ABCE1 ATM | 7.91e-12 | 653 | 204 | 23 | 22586326 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SPTAN1 SPTBN2 RPL10A CDC40 SACS PTPRO CLK1 PAN2 DHX35 NME1 NIPBL HSPA5 ARHGEF6 KRT16 HDAC6 KALRN DSP NSD2 SYNE1 CECR2 HECTD4 UFL1 XPO1 GTF2IRD1 PRPF8 LMNA DROSHA ATM PCMT1 | 1.01e-11 | 1082 | 204 | 29 | 38697112 |
| Pubmed | EPRS1 NCKAP1 TRIO SPTAN1 SPTBN2 PSMC3 TSC1 ALDH1L1 RPL10A SACS EIF3L GLUD2 NUFIP2 FGG HSPA5 WNK2 MOG KRT16 KALRN DSP SYNE1 DLGAP4 ARHGEF12 POR COPS3 XPO1 ARPC4 ADAM22 ARHGAP5 LMNA USO1 SLC4A10 SLC4A4 | 1.79e-11 | 1431 | 204 | 33 | 37142655 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR ATR STAG1 SPTAN1 VPS33A PSMC3 FANCD2 NIPBL HSPA5 KNL1 CCZ1B DSP COPS3 SMC2 PRPF8 CCNB1 LMNA CCZ1 USO1 ATM | 3.03e-10 | 582 | 204 | 20 | 20467437 |
| Pubmed | EPRS1 DCHS2 STAG1 TRIO SPTAN1 SPTBN2 TTLL12 CCDC13 SACS CLK1 DHX35 ZNF606 SULT4A1 NIPBL HSPA5 USP47 AKAP6 DOCK3 HDAC6 KALRN DSP USP28 SYNE1 HECTD4 PRPF8 ADAM22 ARHGAP5 DROSHA ATM | 5.67e-10 | 1285 | 204 | 29 | 35914814 | |
| Pubmed | NUSAP1 TRIO SPTAN1 SPTBN2 PSMC3 TSC1 BCOR FANCD2 CLNS1A NUFIP2 KIF14 HSPA5 KNL1 WDR48 KRT16 DSP NSD2 CEP162 CIP2A POR XPO4 XPO1 PPEF1 ARHGAP5 IGF2R | 3.31e-09 | 1049 | 204 | 25 | 27880917 | |
| Pubmed | TPR EPRS1 NCKAP1 TRIO SPTAN1 VPS33A SNRK RYR2 GLUD2 NUFIP2 NME1 CLEC16A WNK2 DOCK3 AMPD2 SLC4A8 NAA15 KALRN DSP DLGAP4 POR ADAM22 LMNA ABCE1 SLC4A10 SLC4A4 | 3.80e-09 | 1139 | 204 | 26 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR EPRS1 GBF1 NCKAP1 SPTAN1 SPTBN2 PSMC3 RPL10A TTLL12 CLNS1A EIF3L NUFIP2 NME1 HSPA5 PNP NAA15 FNTA DSP CIP2A COPS3 XPO1 NR3C1 SMC2 PRPF8 USO1 PCMT1 | 4.55e-09 | 1149 | 204 | 26 | 35446349 |
| Pubmed | TPR EPRS1 SPTAN1 PSMC3 RPL10A EIF3L NUFIP2 NME1 HSPA5 CFAP47 KIF23 NAA15 DSP XPO1 LMNA USO1 PCMT1 | 6.75e-09 | 494 | 204 | 17 | 26831064 | |
| Pubmed | EFCAB5 TPT1 EPRS1 STAG1 KRT74 SPTAN1 SPTBN2 TSC1 RYR2 ABCB1 SACS GCLC GLUD2 CC2D2A NME1 NIPBL HSPA5 RPGRIP1 KRT16 DSP NSD2 SYNE1 GPS1 SMC2 PRPF8 ARPC4 CCDC148 LMNA ATM | 7.55e-09 | 1442 | 204 | 29 | 35575683 | |
| Pubmed | EPRS1 GBF1 NCKAP1 SPTAN1 PSMC3 RPL10A TTLL12 COQ8A EIF3L HSPA5 NAA15 CIP2A GPS1 UFL1 XPO1 SMC2 PRPF8 LMNA USO1 | 8.81e-09 | 638 | 204 | 19 | 33239621 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ACP6 TPT1 EPRS1 GBF1 NCKAP1 CDK15 PSMC3 SNRK TSC1 GIT2 TSC22D1 EIF3L KIF23 FNTA DSP CEP162 GPS1 XPO4 UFL1 COPS3 SMC2 PRPF8 ARPC4 USO1 ZNF277 ADI1 PCMT1 | 1.04e-08 | 1284 | 204 | 27 | 17353931 |
| Pubmed | TPT1 EPRS1 NCKAP1 PSMC3 TSC1 RPL10A EIF3L HSPA5 DNAH3 NAA15 KRT16 DSP CEP162 SYNE1 XPO1 SMC2 PRPF8 ARPC4 LMNA ABCE1 PCMT1 | 1.35e-08 | 803 | 204 | 21 | 36517590 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 DOCK11 RNF112 SPTBN2 RYR1 FANCA TTLL12 CLNS1A EIF3L HSPA5 CFAP47 DNAH3 DSP PRPF8 ARHGAP5 LMNA ABCE1 DROSHA ATM PCMT1 | 1.62e-08 | 736 | 204 | 20 | 29676528 |
| Pubmed | TPR EPRS1 DOCK11 PSMC3 NUFIP2 USP47 DSP POR UFL1 COPS3 XPO1 SMC2 ARPC4 USO1 PCMT1 | 1.68e-08 | 399 | 204 | 15 | 37536630 | |
| Pubmed | NCKAP1 AVL9 KIAA0232 TSC1 KLHL13 NUFIP2 ANKRD12 CLEC16A WDR48 SYNE1 DLGAP4 ARHGEF12 TRAK1 DZIP3 LARGE1 | 2.19e-08 | 407 | 204 | 15 | 12693553 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NUSAP1 EPRS1 GBF1 NCKAP1 SPTAN1 PSMC3 RRAGB FANCD2 TTLL12 TSC22D1 GCLC CLNS1A EIF3L NME1 HSPA5 USP47 PNP AMPD2 NAA15 FNTA GPS1 COPS3 XPO1 NR3C1 SMC2 ARPC4 LMNA ABCE1 | 3.57e-08 | 1455 | 204 | 28 | 22863883 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR EPRS1 NCKAP1 SPTAN1 PSMC3 TSC1 RPL10A FBXO22 EIF3L SCO1 NME1 NIPBL HSPA5 AMPD2 NAA15 KRT16 HDAC6 DSP UFL1 XPO1 SMC2 PRPF8 ARPC4 LMNA USO1 ADI1 PCMT1 | 7.62e-08 | 1415 | 204 | 27 | 28515276 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 PSMC3 RPL10A FANCD2 FBXO22 PTPRO CLNS1A SCO1 HSPA5 USP47 NAA15 FNTA VPS26B CIP2A GPS1 XPO4 XPO1 SMC2 PRPF8 PPEF1 CCNB1 ABCE1 | 7.89e-08 | 974 | 204 | 22 | 28675297 |
| Pubmed | STAG1 SPTAN1 CLNS1A NIPBL HSPA5 WDR48 KIF23 DSP DDX60 XPO1 LMNA USO1 | 8.48e-08 | 272 | 204 | 12 | 31010829 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUSAP1 TPR STAG1 INSR TTLL12 CDC40 EIF3L KIF14 DHX35 NIPBL USP47 KNL1 NAA16 KIF23 NAA15 HDAC6 SYNE1 GPS1 COPS3 XPO1 PRPF8 CCNB1 ATM PCMT1 | 9.17e-08 | 1155 | 204 | 24 | 20360068 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 TRIO DOCK11 SPTAN1 PSMC3 NUFIP2 MOG NAA15 KALRN DSP ARHGEF12 UFL1 ARHGAP5 DZIP3 PCMT1 | 1.63e-07 | 475 | 204 | 15 | 31040226 |
| Pubmed | Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. | 1.99e-07 | 3 | 204 | 3 | 16943440 | |
| Pubmed | TPT1 NCKAP1 TRIO ERAP1 SPTAN1 VPS33A PSMC3 FBXO22 CLNS1A EIF3L NUFIP2 ECEL1 NIPBL HSPA5 PNP KIF23 DSP UFL1 XPO1 PRPF8 CCNB1 TGFB1 IGF2R ADI1 PCMT1 | 2.00e-07 | 1297 | 204 | 25 | 33545068 | |
| Pubmed | TPR EPRS1 SNX3 RPL10A TTLL12 EIF3L PNP NAA15 KRT16 XPO1 PRPF8 ARPC4 LMNA ABCE1 PCMT1 | 2.49e-07 | 491 | 204 | 15 | 22623428 | |
| Pubmed | EFCAB5 EPRS1 CDK15 FANCD2 FBXO22 EIF3L HSPA5 USP47 PNP NAA15 DSP USP28 GPS1 COPS3 XPO1 NR3C1 PRPF8 IGF2R USO1 PCMT1 | 2.79e-07 | 878 | 204 | 20 | 37223481 | |
| Pubmed | TPR EPRS1 KRT74 SPTAN1 RPL10A TTLL12 CDC40 EIF3L NUFIP2 HSPA5 KRT16 DSP XPO1 SMC2 PRPF8 ARPC4 LMNA | 2.84e-07 | 641 | 204 | 17 | 36057605 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR EPRS1 DYM ERAP1 SPTAN1 PSMC3 RPL10A EIF3L NME1 HSPA5 DSP CIP2A XPO4 XPO1 ARPC4 LMNA PCMT1 | 3.23e-07 | 647 | 204 | 17 | 26618866 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR EPRS1 NCKAP1 SPTAN1 PSMC3 TSC1 RPL10A FBXO22 CDC40 EIF3L NIPBL HSPA5 PNP KIF23 NAA15 HDAC6 DSP COPS3 XPO1 SMC2 PRPF8 ARPC4 LMNA ABCE1 PCMT1 | 4.38e-07 | 1353 | 204 | 25 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR TPT1 EPRS1 NCKAP1 SPTAN1 SPTBN2 VPS33A PSMC3 EIF3L SCO1 NME1 NIPBL HSPA5 DNAH3 NAA15 DSP SMC2 PRPF8 ARPC4 | 7.06e-07 | 847 | 204 | 19 | 35235311 |
| Pubmed | SPTAN1 PSMC3 RPL10A FANCD2 TTLL12 COQ8A NUFIP2 NME1 HSPA5 DSP SYNE1 XPO1 PRPF8 LMNA | 7.13e-07 | 463 | 204 | 14 | 34901782 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR EPRS1 SPTAN1 PSMC3 TTLL12 NIPBL HSPA5 KIF23 XPO1 SMC2 PRPF8 LMNA | 7.14e-07 | 332 | 204 | 12 | 32786267 |
| Pubmed | FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. | 7.92e-07 | 4 | 204 | 3 | 18931676 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR EPRS1 GBF1 ATR SPTAN1 BCOR FANCD2 NIPBL ARHGEF6 USP47 KIF23 HDAC6 DSP UFL1 XPO1 GTF2IRD1 LMNA ATM | 8.41e-07 | 774 | 204 | 18 | 15302935 |
| Pubmed | GBF1 ERAP1 KIAA0232 SNRK GIT2 CLEC16A WDR48 AKAP6 SYNE1 PRDM16 | 9.69e-07 | 225 | 204 | 10 | 12168954 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ATR TSC1 ALDH1L1 ABCB1 FANCA ACCS XRCC2 CCNB1 TGFB1 IGF2R ATM CDH12 | 1.28e-06 | 351 | 204 | 12 | 20453000 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | TPT1 EPRS1 SPTAN1 VPS33A PSMC3 ALDH1L1 RYR1 RPL10A NME1 HSPA5 PNP DSP SYNE1 COPS3 PRPF8 ARPC4 LMNA ABCE1 | 1.52e-06 | 807 | 204 | 18 | 30575818 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ACP6 EPRS1 GBF1 VPS33A PSMC3 RRAGB RPL10A COQ8A KLHL13 GLUD2 NME1 HSPA5 PNP WDR48 CCZ1B DSP XPO1 SMC2 PRPF8 CCZ1 ABCE1 RRAGA PCMT1 | 1.55e-06 | 1257 | 204 | 23 | 37317656 |
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 1.60e-06 | 34 | 204 | 5 | 16889989 | |
| Pubmed | TPR EPRS1 SNX3 NUFIP2 PAN2 NIPBL ARHGEF6 USP47 AMPD2 KIF23 HDAC6 KALRN GPS1 LMNA | 1.88e-06 | 503 | 204 | 14 | 16964243 | |
| Pubmed | 2.48e-06 | 102 | 204 | 7 | 11214970 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR EPRS1 SPTBN2 INSR ABCB1 RPL10A SACS KIF14 NIPBL HSPA5 KRT16 DSP SYNE1 UFL1 XPO1 SMC2 PRPF8 IGF2R LMNA PCMT1 | 2.95e-06 | 1024 | 204 | 20 | 24711643 |
| Pubmed | 2.98e-06 | 255 | 204 | 10 | 15324660 | ||
| Pubmed | NCKAP1 EIF3L ZNF606 HSPA5 WNK2 NAA15 KRT16 GPS1 UFL1 XPO1 LMNA ABCE1 TADA2B | 3.03e-06 | 451 | 204 | 13 | 36168627 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.09e-06 | 256 | 204 | 10 | 33397691 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 NCKAP1 PSMC3 FANCA FANCD2 TTLL12 EIF3L NUFIP2 FAM8A1 AMPD2 NAA15 CIP2A GPS1 POR UFL1 XPO1 CCNB1 IGF2R USO1 | 3.34e-06 | 942 | 204 | 19 | 31073040 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.35e-06 | 202 | 204 | 9 | 33005030 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NCKAP1 PSMC3 GIT2 CCDC122 EIF3L NUFIP2 PAN2 SCO1 HSPA5 ARHGEF6 WDR48 RPGRIP1 AMPD2 CIP2A GPS1 XPO4 COPS3 SMC2 PRPF8 ARPC4 METTL9 DZIP3 LARGE1 | 3.53e-06 | 1321 | 204 | 23 | 27173435 |
| Pubmed | EPRS1 PSMC3 FBXO22 CLNS1A ECEL1 NME1 HSPA5 GPS1 COPS3 SMC2 PRPF8 TGFB1 IGF2R LMNA ABCE1 | 3.88e-06 | 613 | 204 | 15 | 22268729 | |
| Pubmed | 3.93e-06 | 6 | 204 | 3 | 9211987 | ||
| Pubmed | Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. | 3.93e-06 | 6 | 204 | 3 | 24529380 | |
| Pubmed | SNX3 ATR ALDH1L1 ABCB1 C1QTNF3 NIPBL DSP NSD2 NR3C1 TGFB1 PRDM16 | 4.67e-06 | 331 | 204 | 11 | 20634891 | |
| Pubmed | TPR EPRS1 SNX3 RPL10A TTLL12 CLNS1A EIF3L HSPA5 NAA15 KRT16 XPO1 PRPF8 ARPC4 IGF2R LMNA PCMT1 | 4.93e-06 | 707 | 204 | 16 | 19738201 | |
| Pubmed | TPR EPRS1 GBF1 NCKAP1 SPTAN1 PSMC3 RPL10A TTLL12 EIF3L HSPA5 NAA15 DSP UFL1 XPO1 PRPF8 ABCE1 | 5.30e-06 | 711 | 204 | 16 | 33022573 | |
| Pubmed | TPR EPRS1 SPTAN1 SPTBN2 RPL10A CLNS1A EIF3L NUFIP2 HSPA5 HDAC6 DSP PRPF8 LMNA PCMT1 | 5.37e-06 | 551 | 204 | 14 | 34728620 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUSAP1 TPR EPRS1 SPTAN1 SPTBN2 RPL10A CDC40 EIF3L NUFIP2 KIF14 HSPA5 KIF23 NAA15 KRT16 DSP DDX60 XPO1 SMC2 PRPF8 ARPC4 LMNA ATP4A | 5.37e-06 | 1257 | 204 | 22 | 36526897 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 ATR SPTAN1 SPTBN2 CDC40 EIF3L NUFIP2 NME1 HSPA5 DSP PRPF8 LMNA DROSHA | 5.55e-06 | 477 | 204 | 13 | 31300519 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 SPTAN1 PSMC3 RPL10A CDC40 CLK1 EIF3L NUFIP2 NME1 HSPA5 SYNE1 XPO1 PRPF8 ARPC4 LMNA DROSHA | 5.58e-06 | 714 | 204 | 16 | 28302793 |
| Pubmed | TPR GBF1 TRIO ERAP1 SPTBN2 RPL10A WDR48 USP28 DDX60 CIP2A GPS1 COPS3 XRCC2 CCNB1 IGF2R | 5.81e-06 | 634 | 204 | 15 | 34591612 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPT1 GBF1 NCKAP1 ERAP1 RPL10A HSPA5 KNL1 AMPD2 KIF23 NAA15 HDAC6 DSP GPS1 COPS3 XPO1 NR3C1 SMC2 PRPF8 ARPC4 IGF2R USO1 ABCE1 PCMT1 | 6.17e-06 | 1367 | 204 | 23 | 32687490 |
| Pubmed | TPR KIAA0232 SPTAN1 SPTBN2 FAM13B TSC22D1 HSPA5 WNK2 DSP SYNE1 TGFB1 MAPK7 SLC4A4 | 6.78e-06 | 486 | 204 | 13 | 20936779 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 7.02e-06 | 281 | 204 | 10 | 30455355 | |
| Pubmed | TRIO SPTAN1 VPS33A HSPA5 KRT16 DSP ARHGEF12 SMC2 ATP4A PCMT1 | 7.70e-06 | 284 | 204 | 10 | 29459677 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 7.94e-06 | 170 | 204 | 8 | 19064572 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | SPTAN1 PSMC3 KLHL13 CLNS1A EIF3L CLEC16A HSPA5 HDAC6 GPS1 COPS3 SMC2 USO1 PCMT1 | 8.24e-06 | 495 | 204 | 13 | 28581483 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 8.30e-06 | 226 | 204 | 9 | 37839992 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | TPR PSMC3 RPL10A FANCD2 PTPRO EIF3L SCO1 WDR48 SYNE1 XPO1 PRPF8 PPEF1 SERTAD4 PCMT1 | 8.35e-06 | 573 | 204 | 14 | 28330616 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PSMC3 FBXO22 KLHL13 CLNS1A EIF3L NUFIP2 PAN2 NME1 MOG USP47 WDR48 USP28 GPS1 COPS3 USP37 PRPF8 IGF2R ABCE1 TADA2B | 8.37e-06 | 1005 | 204 | 19 | 19615732 |
| Pubmed | TRIO PSMC3 GIT2 RYR1 CLK1 AKAP6 KALRN DSP SYNE1 ZNF407 CCNB1 LMNA DROSHA | 8.61e-06 | 497 | 204 | 13 | 23414517 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | DYM ATR DOCK11 NUP210L VPS33A FANCD2 PTPRO EIF3L SCO1 KIF14 NME1 CIP2A GPS1 XPO4 HDDC2 XPO1 CCNB1 PCMT1 | 1.08e-05 | 931 | 204 | 18 | 27432908 |
| Pubmed | 1.13e-05 | 50 | 204 | 5 | 23703321 | ||
| Pubmed | TPR RPL10A EIF3L GLUD2 KIF14 NME1 HSPA5 PNP HDAC6 DSP SYNE1 XPO1 PRPF8 ARPC4 LMNA ABCE1 PCMT1 | 1.14e-05 | 844 | 204 | 17 | 25963833 | |
| Pubmed | 1.29e-05 | 87 | 204 | 6 | 37495603 | ||
| Pubmed | 1.32e-05 | 25 | 204 | 4 | 38877142 | ||
| Pubmed | 1.36e-05 | 183 | 204 | 8 | 23956138 | ||
| Pubmed | NUSAP1 EPRS1 VPS33A PSMC3 BCOR RPL10A FANCD2 FBXO22 CLNS1A EIF3L NME1 HSPA5 HDAC6 FNTA GPS1 COPS3 XPO1 PRPF8 ARPC4 CCNB1 LMNA PCMT1 | 1.37e-05 | 1335 | 204 | 22 | 29229926 | |
| Pubmed | 1.39e-05 | 241 | 204 | 9 | 23125841 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NUSAP1 TPR EPRS1 SPTAN1 SPTBN2 RPL10A EIF3L NUFIP2 DHX35 HSPA5 KIF23 DSP SYNE1 PRPF8 ARPC4 LMNA TADA2B PCMT1 | 1.40e-05 | 949 | 204 | 18 | 36574265 |
| Pubmed | 1.43e-05 | 305 | 204 | 10 | 33194618 | ||
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 16682347 | ||
| Pubmed | SNRK BCOR COQ8A PAN2 WNK2 AKAP6 NSD2 USP28 CEP162 CECR2 HECTD4 XPO4 UFL1 | 1.66e-05 | 529 | 204 | 13 | 14621295 | |
| Pubmed | ATR STAG1 PSMC3 FANCA FANCD2 FBXO22 KNL1 KIF23 USP28 CIP2A GTF2IRD1 ATM | 1.69e-05 | 453 | 204 | 12 | 29656893 | |
| Pubmed | EFCAB5 TPR RPL10A FBXO22 KIF14 HSPA5 DSP COPS3 LMNA ABCE1 PCMT1 | 1.78e-05 | 382 | 204 | 11 | 37249651 | |
| Pubmed | 1.91e-05 | 251 | 204 | 9 | 27507650 | ||
| Pubmed | TPT1 EPRS1 SPTAN1 PSMC3 RPL10A HSPA5 NAA15 USP28 DLGAP4 GPS1 SMC2 PRPF8 ARPC4 | 1.98e-05 | 538 | 204 | 13 | 28524877 | |
| Pubmed | 2.11e-05 | 28 | 204 | 4 | 20012529 | ||
| Pubmed | TPR EPRS1 NCKAP1 RPL10A NUFIP2 HSPA5 HDAC6 DSP CIP2A ARHGEF12 XPO1 SMC2 IGF2R USO1 ABCE1 | 2.12e-05 | 708 | 204 | 15 | 39231216 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 2.16e-05 | 57 | 204 | 5 | 23788249 | |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 18434328 | ||
| Pubmed | TPT1 ERAP1 SPTAN1 VPS33A PSMC3 SNRK CCDC122 RYR1 RPL10A KLHL13 ANKRD12 AKAP6 CCZ1B GPS1 POR HDDC2 UFL1 COPS3 TGFB1 MST1R SERTAD4 | 2.69e-05 | 1293 | 204 | 21 | 15342556 | |
| Pubmed | SNX3 RYR1 FANCA WNK2 AKAP6 DOCK3 HDAC6 DLGAP4 GTF2IRD1 DROSHA | 2.73e-05 | 329 | 204 | 10 | 17474147 | |
| Pubmed | Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models. | 3.17e-05 | 11 | 204 | 3 | 27766308 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 3.17e-05 | 11 | 204 | 3 | 17607528 | |
| Pubmed | 3.17e-05 | 11 | 204 | 3 | 17475776 | ||
| Pubmed | 3.19e-05 | 31 | 204 | 4 | 19690177 | ||
| Pubmed | 3.26e-05 | 151 | 204 | 7 | 17043677 | ||
| Pubmed | EPRS1 ATR FANCA TTLL12 CDC40 COQ8A DENND5A CLEC16A WDR48 NAA15 NR3C1 SMC2 ABCE1 DROSHA | 3.36e-05 | 650 | 204 | 14 | 38777146 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SNX3 NCKAP1 ALDH1L1 RYR1 ABCB1 PTPRO FGG NIPBL HSPA5 PNP NAA16 KALRN DSP ARHGEF12 SMC2 ARPC4 IGF2R SLC4A4 | 3.42e-05 | 1016 | 204 | 18 | 19056867 |
| Interaction | BRCA1 interactions | TPR EPRS1 SNX3 GBF1 ATR STAG1 TRIO ERAP1 SPTAN1 PSMC3 FANCA RPL10A FANCD2 EIF3L NUFIP2 NME1 NIPBL HSPA5 KNL1 WDR48 CFAP47 RPGRIP1 FAM184A KIF23 NAA15 FNTA DSP NSD2 USP28 CIP2A XPO1 USP37 GTF2IRD1 CCNB1 LMNA USO1 DZIP3 ATM PCMT1 | 1.85e-10 | 1249 | 202 | 39 | int:BRCA1 |
| Interaction | GPR17 interactions | DYM GBF1 ATR STAG1 ERAP1 RRAGB FANCA FANCD2 SACS USP28 CIP2A XPO4 UFL1 XPO1 USO1 ATM | 2.88e-08 | 283 | 202 | 16 | int:GPR17 |
| Interaction | SPN interactions | 9.62e-08 | 57 | 202 | 8 | int:SPN | |
| Interaction | SIRT7 interactions | TPR ATR NCKAP1 SPTAN1 SPTBN2 PSMC3 RPL10A TTLL12 EIF3L NUFIP2 KIF14 NIPBL USP47 PNP KIF23 NAA15 DSP NSD2 XPO1 PRPF8 CCNB1 IGF2R LMNA ABCE1 ATM | 1.25e-07 | 744 | 202 | 25 | int:SIRT7 |
| Interaction | CDC5L interactions | TPR ATR TRIO SPTAN1 VPS33A PSMC3 FANCD2 CDC40 KIF14 NIPBL HSPA5 KNL1 AKAP6 CCZ1B KALRN DSP SYNE1 UFL1 SMC2 PRPF8 TRAK1 CCNB1 LMNA CCZ1 USO1 DZIP3 PRDM16 | 1.31e-07 | 855 | 202 | 27 | int:CDC5L |
| Interaction | PRKDC interactions | TPR TPT1 ATR FANCD2 COQ8A CLK1 PAN2 KIF14 HSPA5 ARHGEF6 KIF23 NAA15 HDAC6 DSP UFL1 NR3C1 PRPF8 PPEF1 CCNB1 TGFB1 MST1R LMNA DZIP3 ATM | 1.39e-07 | 695 | 202 | 24 | int:PRKDC |
| Interaction | TMPO interactions | NUSAP1 EPRS1 STAG1 SPTAN1 ARL5A RPL10A FANCD2 NEK3 FBXO22 COQ8A CLK1 EIF3L KIF14 CLEC16A HSPA5 KIF23 HDAC6 NSD2 POR UFL1 PRPF8 ARPC4 ARL5B LMNA ABCE1 | 1.96e-07 | 762 | 202 | 25 | int:TMPO |
| Interaction | SMARCA5 interactions | TPR STAG1 FANCD2 FBXO22 KIF14 CLEC16A HSPA5 KIF23 NSD2 CECR2 GPS1 COPS3 SMC2 MST1R LMNA ABCE1 ATM PRDM16 | 2.16e-07 | 415 | 202 | 18 | int:SMARCA5 |
| Interaction | SMC1A interactions | SNX3 ATR STAG1 VPS33A FANCD2 KIF14 NIPBL WNK2 NR3C1 USP37 SMC2 PRPF8 TGFB1 MST1R LMNA ABCE1 DZIP3 ATM | 2.40e-07 | 418 | 202 | 18 | int:SMC1A |
| Interaction | FPR1 interactions | 2.82e-07 | 147 | 202 | 11 | int:FPR1 | |
| Interaction | DNAJA1 interactions | TPT1 SPTAN1 INSR TSC1 FANCD2 PAN2 SPDYE4 HSPA5 AMPD2 HDAC6 CIP2A GPS1 UFL1 COPS3 SMC2 PRPF8 PPEF1 TGFB1 USO1 MAPK7 | 4.52e-07 | 533 | 202 | 20 | int:DNAJA1 |
| Interaction | FLNA interactions | EPRS1 NCKAP1 TRIO SPTAN1 SPTBN2 FANCD2 PAN2 KIF14 NIPBL HSPA5 KIF23 HDAC6 TTC41P NSD2 CEP162 UFL1 PRPF8 ARPC4 CCNB1 TGFB1 LMNA ABCE1 | 6.36e-07 | 648 | 202 | 22 | int:FLNA |
| Interaction | VSIG2 interactions | 6.87e-07 | 32 | 202 | 6 | int:VSIG2 | |
| Interaction | PHIP interactions | TPR BCOR COQ8A KIF14 HSPA5 KIF23 HDAC6 CECR2 GPS1 COPS3 LMNA PRDM16 | 7.44e-07 | 197 | 202 | 12 | int:PHIP |
| Interaction | COMTD1 interactions | EPRS1 DYM GBF1 FANCD2 FAM8A1 USP28 CIP2A XPO4 UFL1 XPO1 SMC2 USO1 | 8.74e-07 | 200 | 202 | 12 | int:COMTD1 |
| Interaction | PDIA6 interactions | GBF1 INSR FANCD2 PTPRO CLNS1A KIF14 CLEC16A HSPA5 USP47 KIF23 HDAC6 UFL1 NR3C1 PRPF8 ARPC4 | 1.15e-06 | 327 | 202 | 15 | int:PDIA6 |
| Interaction | RUVBL1 interactions | PSMC3 TSC1 FANCD2 PAN2 NME1 NIPBL HSPA5 USP47 KIF23 HDAC6 GPS1 UFL1 COPS3 XPO1 SMC2 PRPF8 TGFB1 LMNA DZIP3 MAPK7 | 1.47e-06 | 575 | 202 | 20 | int:RUVBL1 |
| Interaction | EEF1A1P5 interactions | 1.62e-06 | 141 | 202 | 10 | int:EEF1A1P5 | |
| Interaction | HDAC6 interactions | EPRS1 GBF1 NCKAP1 ERAP1 SPTAN1 SPTBN2 BCOR RPL10A NEK3 EIF3L KIF14 CLEC16A HSPA5 USP47 KIF23 KRT16 HDAC6 FNTA DSP XPO1 NR3C1 PRPF8 ARPC4 LMNA ATM PCMT1 | 2.22e-06 | 929 | 202 | 26 | int:HDAC6 |
| Interaction | TRAFD1 interactions | 2.26e-06 | 60 | 202 | 7 | int:TRAFD1 | |
| Interaction | VTN interactions | FANCD2 KIF14 FGG CLEC16A KIF23 HDAC6 DSP UFL1 NR3C1 PRPF8 TGFB1 | 2.48e-06 | 183 | 202 | 11 | int:VTN |
| Interaction | EIF3E interactions | GBF1 VPS33A FANCD2 EIF3L KIF14 KIF23 DDX60 UFL1 XPO1 PRPF8 ABCE1 ATM PRDM16 | 2.68e-06 | 263 | 202 | 13 | int:EIF3E |
| Interaction | YWHAZ interactions | GBF1 NCKAP1 DOCK11 KIAA0232 SPTAN1 SPTBN2 TSC1 BCOR FAM13B FANCD2 PTPRO KIF14 NME1 HSPA5 ARHGEF6 WNK2 USP47 AMPD2 KIF23 HDAC6 CEP162 HECTD4 UFL1 XPO1 SMC2 PRPF8 ADAM22 TRAK1 MST1R LMNA ATM MAPK7 | 2.91e-06 | 1319 | 202 | 32 | int:YWHAZ |
| Interaction | TNFSF13B interactions | 3.19e-06 | 119 | 202 | 9 | int:TNFSF13B | |
| Interaction | RPL5 interactions | TPT1 RPL10A FANCD2 TSC22D1 CLK1 EIF3L NUFIP2 PAN2 KIF14 CLEC16A HSPA5 KIF23 HDAC6 UFL1 XPO1 PRPF8 LMNA ABCE1 ATM PRDM16 | 3.25e-06 | 606 | 202 | 20 | int:RPL5 |
| Interaction | DYNLL1 interactions | TPR SNX3 COQ8A PAN2 KIF14 NME1 HSPA5 KIF23 HDAC6 DSP USP28 GPS1 UFL1 COPS3 PRPF8 TRAK1 ABCE1 ATM | 4.11e-06 | 510 | 202 | 18 | int:DYNLL1 |
| Interaction | MOB3C interactions | TPR EPRS1 DOCK11 PSMC3 NUFIP2 FAM118A USP47 DSP POR UFL1 COPS3 XPO1 SMC2 USO1 PCMT1 | 4.29e-06 | 364 | 202 | 15 | int:MOB3C |
| Interaction | MECP2 interactions | NUSAP1 SPTAN1 SPTBN2 RPL10A CDC40 SACS PTPRO CLK1 NUFIP2 PAN2 DHX35 NME1 NIPBL HSPA5 ARHGEF6 KRT16 HDAC6 KALRN DSP NSD2 SYNE1 CECR2 HECTD4 UFL1 XPO1 GTF2IRD1 PRPF8 LMNA DROSHA ATM PCMT1 | 4.92e-06 | 1287 | 202 | 31 | int:MECP2 |
| Interaction | PLS3 interactions | EPRS1 SNX3 GBF1 PSMC3 FANCD2 CLNS1A KIF14 HSPA5 DLGAP4 UFL1 PRPF8 ABCE1 | 5.12e-06 | 237 | 202 | 12 | int:PLS3 |
| Interaction | IMPDH2 interactions | GBF1 FANCD2 COQ8A CLK1 KIF14 NME1 CLEC16A HSPA5 KIF23 HDAC6 DSP CIP2A ARHGEF12 UFL1 SMC2 TGFB1 | 5.55e-06 | 420 | 202 | 16 | int:IMPDH2 |
| Interaction | TRIM37 interactions | KRT74 SPTAN1 RRAGB BCOR RPL10A KIF14 ANKRD12 FGG NME1 HSPA5 MOG RPGRIP1 KIF23 DSP XPO1 CCNB1 LMNA USO1 ATM PCMT1 | 5.79e-06 | 630 | 202 | 20 | int:TRIM37 |
| Interaction | RAN interactions | NUSAP1 TPR EPRS1 TSC1 FANCD2 FBXO22 PAN2 KIF14 HSPA5 KIF23 HDAC6 DSP XPO4 UFL1 XPO1 NR3C1 LMNA | 6.41e-06 | 475 | 202 | 17 | int:RAN |
| Interaction | MAGED2 interactions | TPT1 TSC1 FANCD2 COQ8A KIF14 HSPA5 DOCK3 KIF23 UFL1 XPO1 DZIP3 PRDM16 | 6.60e-06 | 243 | 202 | 12 | int:MAGED2 |
| Interaction | RPL38 interactions | TPT1 RPL10A FANCD2 PAN2 SCO1 KIF14 HSPA5 KIF23 HDAC6 NSD2 UFL1 PRPF8 PPEF1 TGFB1 | 7.44e-06 | 334 | 202 | 14 | int:RPL38 |
| Interaction | EFTUD2 interactions | TPR EPRS1 NCKAP1 SPTAN1 PSMC3 RPL10A FANCD2 FBXO22 CDC40 EIF3L PAN2 SCO1 KIF14 DHX35 NME1 NIPBL HSPA5 AMPD2 KIF23 NAA15 KRT16 HDAC6 DSP UFL1 COPS3 USP37 SMC2 PRPF8 PPEF1 ARPC4 LMNA ADI1 PCMT1 | 7.64e-06 | 1449 | 202 | 33 | int:EFTUD2 |
| Interaction | PRPF6 interactions | TSNAXIP1 SNRK RPL10A FANCD2 FBXO22 KIF14 NME1 HSPA5 KIF23 UFL1 PRPF8 TRAK1 LMNA USO1 | 7.96e-06 | 336 | 202 | 14 | int:PRPF6 |
| Interaction | JUP interactions | GBF1 STAG1 CDK15 SPTAN1 INSR RPL10A FANCD2 PAN2 KIF14 NME1 HSPA5 KIF23 HDAC6 DSP PRPF8 ABCE1 MAPK7 | 8.42e-06 | 485 | 202 | 17 | int:JUP |
| Interaction | CORO1C interactions | GBF1 FANCD2 FBXO22 PTPRO PAN2 KIF14 HSPA5 KIF23 HDAC6 POR UFL1 MST1R ABCE1 MAPK7 | 8.51e-06 | 338 | 202 | 14 | int:CORO1C |
| Interaction | MAP1B interactions | EPRS1 PSMC3 FANCD2 COQ8A GLUD2 PAN2 NME1 HSPA5 NSD2 SYNE1 GPS1 UFL1 COPS3 XPO1 PRPF8 LMNA ABCE1 PRDM16 | 8.78e-06 | 539 | 202 | 18 | int:MAP1B |
| Interaction | KCTD13 interactions | EPRS1 NCKAP1 TRIO SPTAN1 SPTBN2 PSMC3 TSC1 ALDH1L1 RPL10A SACS EIF3L NUFIP2 FGG HSPA5 WNK2 MOG KRT16 KALRN DSP SYNE1 DLGAP4 ARHGEF12 POR COPS3 XPO1 ARPC4 ADAM22 ARHGAP5 LMNA USO1 SLC4A10 SLC4A4 | 9.12e-06 | 1394 | 202 | 32 | int:KCTD13 |
| Interaction | DOCK7 interactions | TSC1 FANCD2 PAN2 KIF14 HSPA5 KIF23 HDAC6 GPS1 UFL1 COPS3 XPO1 CCNB1 | 1.03e-05 | 254 | 202 | 12 | int:DOCK7 |
| Interaction | EPB41L2 interactions | TPR GBF1 SPTAN1 ARL5A CLNS1A NUFIP2 KIF14 HSPA5 HDAC6 GPS1 COPS3 ABCE1 PCMT1 | 1.08e-05 | 299 | 202 | 13 | int:EPB41L2 |
| Interaction | PFKL interactions | VPS33A FANCD2 COQ8A HSPA5 KIF23 HDAC6 CEP162 DDX60 PRPF8 ABCE1 PRDM16 | 1.11e-05 | 214 | 202 | 11 | int:PFKL |
| Interaction | CFTR interactions | TPR EPRS1 DYM ERAP1 KRT74 SPTAN1 MC3R PSMC3 RYR2 RPL10A TSC22D1 EIF3L ACCS DHX35 NME1 HSPA5 PNP AKAP6 CFAP47 IKZF2 SLC4A8 KRT16 HDAC6 FNTA DSP USP28 CIP2A XPO4 XPO1 ARPC4 TGFB1 LMNA PCMT1 | 1.18e-05 | 1480 | 202 | 33 | int:CFTR |
| Interaction | ACSL3 interactions | DOCK11 INSR FANCD2 COQ8A KIF14 CLEC16A KIF23 UFL1 NR3C1 PPEF1 LMNA MAPK7 | 1.21e-05 | 258 | 202 | 12 | int:ACSL3 |
| Interaction | HSP90AB1 interactions | GBF1 CDK15 SPTAN1 PSMC3 SNRK TSC1 ARL5A FANCA RPL10A FANCD2 PAN2 KIF14 NME1 HSPA5 KIF23 HDAC6 DSP GPS1 UFL1 COPS3 XPO1 NR3C1 PRPF8 IGF2R MAPK7 | 1.22e-05 | 960 | 202 | 25 | int:HSP90AB1 |
| Interaction | P2RY8 interactions | 1.36e-05 | 179 | 202 | 10 | int:P2RY8 | |
| Interaction | STK31 interactions | 1.62e-05 | 16 | 202 | 4 | int:STK31 | |
| Interaction | MSH2 interactions | TPT1 ATR VPS33A ALDH1L1 FANCA FANCD2 HSPA5 HDAC6 XPO1 PRPF8 LMNA DZIP3 ATM | 1.75e-05 | 313 | 202 | 13 | int:MSH2 |
| Interaction | KLHL4 interactions | 1.82e-05 | 33 | 202 | 5 | int:KLHL4 | |
| Interaction | NUP93 interactions | TPR FANCD2 TSC22D1 PAN2 SCO1 KIF14 FGG HSPA5 KIF23 XPO1 LMNA PRDM16 | 1.83e-05 | 269 | 202 | 12 | int:NUP93 |
| Interaction | EED interactions | TPR TPT1 EPRS1 SNX3 STAG1 NCKAP1 TRIO SPTAN1 BCOR RPL10A FANCD2 TTLL12 TSC22D1 EIF3L NIPBL HSPA5 NAA15 DSP NSD2 CIP2A XPO4 COPS3 XPO1 SMC2 PRPF8 ARPC4 ARL5B IGF2R LMNA USO1 ABCE1 DROSHA | 1.88e-05 | 1445 | 202 | 32 | int:EED |
| Interaction | SNW1 interactions | TSNAXIP1 TPR ATR STAG1 SPTAN1 PSMC3 FANCD2 CDC40 KIF14 DHX35 NIPBL HSPA5 DSP UFL1 COPS3 PRPF8 TRAK1 CCNB1 LMNA USO1 ATM | 2.11e-05 | 747 | 202 | 21 | int:SNW1 |
| Interaction | DCAF7 interactions | TPT1 KIAA0232 ALDH1L1 BCOR FANCD2 FBXO22 COQ8A KIF14 CLEC16A NIPBL DSP XPO1 ARL5B DZIP3 | 2.20e-05 | 368 | 202 | 14 | int:DCAF7 |
| Interaction | TOP1 interactions | TPR TPT1 TSC1 FANCD2 CDC40 NUFIP2 KIF14 NIPBL KIF23 HDAC6 FNTA NSD2 RCVRN UFL1 NR3C1 PRPF8 CCNB1 LMNA ATM PRDM16 | 2.45e-05 | 696 | 202 | 20 | int:TOP1 |
| Interaction | CD40 interactions | 2.45e-05 | 153 | 202 | 9 | int:CD40 | |
| Interaction | SLC3A2 interactions | ARL5A FANCD2 PTPRO KIF14 HSPA5 KIF23 HDAC6 GPS1 UFL1 NR3C1 PRPF8 MAPK7 PRDM16 LARGE1 | 2.48e-05 | 372 | 202 | 14 | int:SLC3A2 |
| Interaction | DSP interactions | TPR EPRS1 STAG1 CDK15 RYR1 FANCD2 KIF14 NME1 HSPA5 KIF23 KRT16 HDAC6 DSP NR3C1 PRPF8 | 2.54e-05 | 423 | 202 | 15 | int:DSP |
| Interaction | STIP1 interactions | TPR EPRS1 GBF1 NCKAP1 SPTAN1 PSMC3 RPL10A FANCD2 TTLL12 COQ8A CLK1 EIF3L SPDYE4 HSPA5 NAA15 HDAC6 DDX60 CIP2A GPS1 UFL1 XPO1 SMC2 PRPF8 LMNA USO1 | 2.68e-05 | 1006 | 202 | 25 | int:STIP1 |
| Interaction | ENO1 interactions | GBF1 ATR ERAP1 FANCA FANCD2 CLK1 KIF14 PNP KIF23 HDAC6 VPS26B NSD2 DLGAP4 GPS1 UFL1 SMC2 PRPF8 ARPC4 LMNA PCMT1 | 2.72e-05 | 701 | 202 | 20 | int:ENO1 |
| Interaction | SMC4 interactions | SPTAN1 PSMC3 BCOR FANCD2 FBXO22 USP47 KIF23 GPS1 SMC2 PRPF8 TGFB1 ABCE1 | 2.82e-05 | 281 | 202 | 12 | int:SMC4 |
| Interaction | RNF123 interactions | EPRS1 DOCK11 RNF112 SPTBN2 RYR1 FANCA TTLL12 CLNS1A EIF3L HSPA5 CFAP47 DNAH3 DSP NR3C1 PRPF8 ARHGAP5 LMNA ZNF277 ABCE1 DROSHA ATM PCMT1 | 2.91e-05 | 824 | 202 | 22 | int:RNF123 |
| Interaction | PLEC interactions | GBF1 ATR SPTAN1 FANCD2 PAN2 KIF14 HSPA5 DNAH3 KIF23 KRT16 HDAC6 NSD2 SMC2 PRPF8 PAPPA | 3.06e-05 | 430 | 202 | 15 | int:PLEC |
| Interaction | CHCHD3 interactions | FAM13B FANCD2 SACS PAN2 SCO1 KIF14 HSPA5 RPGRIP1 KIF23 UFL1 NR3C1 TRAK1 | 3.12e-05 | 284 | 202 | 12 | int:CHCHD3 |
| Interaction | QPCTL interactions | 3.15e-05 | 89 | 202 | 7 | int:QPCTL | |
| Interaction | SRPRB interactions | SNX3 INSR ARL5A FANCD2 TSC22D1 FBXO22 PTPRO KIF14 CLEC16A KIF23 POR ARL5B LMNA | 3.33e-05 | 333 | 202 | 13 | int:SRPRB |
| Interaction | EIF3L interactions | FANCD2 COQ8A EIF3L KIF14 ANKRD12 HSPA5 KIF23 HDAC6 DDX60 XPO1 PRDM16 | 3.73e-05 | 244 | 202 | 11 | int:EIF3L |
| Interaction | PDCD6 interactions | 4.18e-05 | 204 | 202 | 10 | int:PDCD6 | |
| Interaction | ALB interactions | KIAA0232 SPTAN1 RYR2 FANCD2 TSC22D1 SACS PAN2 KIF14 KIF23 KRT16 HDAC6 UFL1 USP37 ATM | 4.27e-05 | 391 | 202 | 14 | int:ALB |
| Interaction | YWHAH interactions | GBF1 NCKAP1 TRIO DOCK11 KIAA0232 SPTAN1 PSMC3 TSC1 GIT2 FANCD2 KIF14 CC2D2A CLEC16A ARHGEF6 WNK2 AMPD2 KIF23 DSP CEP162 HECTD4 XPO1 NR3C1 TRAK1 MST1R ABCE1 MAPK7 | 4.39e-05 | 1102 | 202 | 26 | int:YWHAH |
| Interaction | TEDC2 interactions | TRIO SPTAN1 VPS33A HSPA5 KRT16 DSP ARHGEF12 SMC2 ATP4A PCMT1 | 4.54e-05 | 206 | 202 | 10 | int:TEDC2 |
| Interaction | EIF3F interactions | FANCD2 EIF3L KIF14 CLEC16A WDR48 KIF23 KRT16 HDAC6 DDX60 UFL1 PRPF8 ABCE1 | 4.67e-05 | 296 | 202 | 12 | int:EIF3F |
| Interaction | HDAC1 interactions | TPR ATR STAG1 SPTAN1 PSMC3 BCOR FANCD2 KIF14 HSPA5 USP47 KNL1 IKZF2 NSD2 CIP2A GPS1 COPS3 XPO1 NR3C1 USP37 SMC2 TRAK1 CCNB1 USO1 DZIP3 ATM PRDM16 | 4.81e-05 | 1108 | 202 | 26 | int:HDAC1 |
| Interaction | CUL4A interactions | TPR EPRS1 GBF1 NCKAP1 ERAP1 ARL5A RPL10A COQ8A GCLC EIF3L KIF14 TMCO3 CLEC16A HSPA5 KIF23 KALRN GPS1 ZNF407 COPS3 XPO1 LMNA ABCE1 | 4.97e-05 | 854 | 202 | 22 | int:CUL4A |
| Interaction | RPL24 interactions | TPT1 RPL10A FANCD2 PAN2 KIF14 HSPA5 KIF23 HDAC6 NSD2 UFL1 XPO1 PRPF8 TGFB1 MST1R | 5.04e-05 | 397 | 202 | 14 | int:RPL24 |
| Interaction | XDH interactions | 5.13e-05 | 21 | 202 | 4 | int:XDH | |
| Interaction | IGKV4-1 interactions | 5.13e-05 | 21 | 202 | 4 | int:IGKV4-1 | |
| Interaction | CSPP1 interactions | 5.14e-05 | 96 | 202 | 7 | int:CSPP1 | |
| Interaction | BAP1 interactions | TPR EPRS1 GBF1 NCKAP1 SPTAN1 SPTBN2 PSMC3 ALDH1L1 BCOR RPL10A TTLL12 CLNS1A EIF3L NUFIP2 NME1 HSPA5 PNP NAA15 FNTA DSP USP28 CIP2A COPS3 XPO1 NR3C1 SMC2 PRPF8 USO1 PCMT1 | 5.15e-05 | 1314 | 202 | 29 | int:BAP1 |
| Interaction | NPY2R interactions | 5.19e-05 | 66 | 202 | 6 | int:NPY2R | |
| Interaction | LOXHD1 interactions | 5.35e-05 | 8 | 202 | 3 | int:LOXHD1 | |
| Interaction | NCL interactions | TPT1 EPRS1 SPTAN1 RYR2 RPL10A FANCD2 CLK1 EIF3L PAN2 KIF14 HSPA5 KIF23 HDAC6 DSP NSD2 UFL1 NR3C1 SMC2 PRPF8 IGF2R LMNA | 5.49e-05 | 798 | 202 | 21 | int:NCL |
| Interaction | NRIP1 interactions | 5.61e-05 | 170 | 202 | 9 | int:NRIP1 | |
| Interaction | PPP6R3 interactions | FANCD2 KIF14 CLEC16A HSPA5 DDX60 GPS1 UFL1 COPS3 XPO1 SMC2 TGFB1 | 6.18e-05 | 258 | 202 | 11 | int:PPP6R3 |
| Interaction | WAPL interactions | 6.42e-05 | 173 | 202 | 9 | int:WAPL | |
| Interaction | GNB1 interactions | FANCD2 PAN2 KIF14 CLEC16A HSPA5 KIF23 HDAC6 KALRN XPO1 NR3C1 MST1R ABCE1 | 6.63e-05 | 307 | 202 | 12 | int:GNB1 |
| Interaction | XRCC5 interactions | TPR TPT1 ATR VPS33A FANCD2 KIF14 KIF23 NAA15 HDAC6 UFL1 XPO1 PRPF8 IGF2R ABCE1 ATM PRDM16 | 6.65e-05 | 515 | 202 | 16 | int:XRCC5 |
| Interaction | NUP210 interactions | 6.72e-05 | 174 | 202 | 9 | int:NUP210 | |
| Interaction | SMC3 interactions | STAG1 FANCD2 FBXO22 KIF14 NIPBL DDX60 ARHGEF12 XPO1 USP37 SMC2 TGFB1 MST1R DZIP3 ATM | 6.75e-05 | 408 | 202 | 14 | int:SMC3 |
| Interaction | RPL21 interactions | TPT1 RPL10A FANCD2 PAN2 KIF14 HSPA5 KIF23 HDAC6 UFL1 XPO1 PRPF8 MST1R ABCE1 | 6.79e-05 | 357 | 202 | 13 | int:RPL21 |
| Interaction | RYR1 interactions | 6.80e-05 | 43 | 202 | 5 | int:RYR1 | |
| Interaction | PKP3 interactions | 6.98e-05 | 136 | 202 | 8 | int:PKP3 | |
| Interaction | DDX1 interactions | TPR FANCD2 CLNS1A NUFIP2 KIF14 FGG KIF23 HDAC6 DLGAP4 UFL1 XPO1 TGFB1 MST1R ABCE1 ATM | 7.08e-05 | 463 | 202 | 15 | int:DDX1 |
| Interaction | ACTG1 interactions | TPR TPT1 NCKAP1 SPTAN1 GIT2 FANCD2 PTPRO HSPA5 HDAC6 UFL1 NR3C1 SMC2 PRPF8 TGFB1 LMNA MAPK7 | 7.45e-05 | 520 | 202 | 16 | int:ACTG1 |
| Interaction | RANBP2 interactions | NUSAP1 TPR TPT1 GBF1 FANCD2 KIF14 CLEC16A GPS1 XPO4 XPO1 SCGN PRPF8 LMNA | 7.59e-05 | 361 | 202 | 13 | int:RANBP2 |
| Interaction | RPS18 interactions | TPT1 RPL10A FANCD2 EIF3L PAN2 KIF14 HSPA5 KIF23 HDAC6 UFL1 XPO1 PRPF8 CCNB1 TGFB1 | 8.09e-05 | 415 | 202 | 14 | int:RPS18 |
| Interaction | NPRL3 interactions | 8.56e-05 | 104 | 202 | 7 | int:NPRL3 | |
| Interaction | STAG1 interactions | 8.56e-05 | 104 | 202 | 7 | int:STAG1 | |
| Interaction | SOX2 interactions | NUSAP1 TPT1 EPRS1 SPTAN1 SPTBN2 VPS33A PSMC3 BCOR RYR1 RPL10A EIF3L NUFIP2 KIF14 FGG NIPBL HSPA5 KNL1 PNP KIF23 DSP GPS1 XPO4 COPS3 XPO1 SMC2 PRPF8 ARPC4 TGFB1 ABCE1 PCMT1 | 8.57e-05 | 1422 | 202 | 30 | int:SOX2 |
| Interaction | H2BC18 interactions | 8.72e-05 | 180 | 202 | 9 | int:H2BC18 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.46e-04 | 3 | 127 | 2 | 287 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.54e-04 | 20 | 127 | 3 | 548 | |
| GeneFamily | Ubiquitin specific peptidases | 6.43e-04 | 56 | 127 | 4 | 366 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.00e-03 | 7 | 127 | 2 | 1113 | |
| GeneFamily | Exportins | 1.00e-03 | 7 | 127 | 2 | 547 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.20e-03 | 66 | 127 | 4 | 722 | |
| GeneFamily | COP9 signalosome | 1.71e-03 | 9 | 127 | 2 | 932 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.76e-03 | 181 | 127 | 6 | 694 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 3.09e-03 | 12 | 127 | 2 | 660 | |
| GeneFamily | Sulfotransferases, cytosolic | 4.22e-03 | 14 | 127 | 2 | 762 | |
| GeneFamily | EF-hand domain containing | 4.53e-03 | 219 | 127 | 6 | 863 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | NUSAP1 TPR EPRS1 ATR STAG1 TRIO TSC22D2 FBXO22 CDC40 KIF14 PLAU NIPBL USP47 KNL1 NAA15 CIP2A SMC2 CCNB1 TGFB1 ARHGAP5 CCZ1 USO1 | 5.52e-08 | 721 | 204 | 22 | M10237 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR TPT1 SNX3 ATR DOCK11 ERAP1 SPTAN1 SNRK GIT2 FAM13B ABCB1 RPL10A PCNX2 SACS CLK1 NUFIP2 ITM2A NIPBL ARHGEF6 USP47 FNTA SYNE1 HECTD4 XPO4 CPA3 XPO1 NR3C1 PRPF8 TGFB1 METTL9 DZIP3 ATM THAP12 | 5.58e-08 | 1492 | 204 | 33 | M40023 |
| Coexpression | GARY_CD5_TARGETS_DN | TPR ATR STAG1 ERAP1 PSMC3 PAN2 KIF14 NME1 HSPA5 PNP KIF23 XPO4 ZNF407 CCNB1 ARL5B ADI1 | 4.00e-07 | 440 | 204 | 16 | M13893 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | NUSAP1 TPR EPRS1 AVL9 KIF14 NAA15 DSP NSD2 SMC2 PRPF8 CCNB1 DROSHA | 6.75e-07 | 250 | 204 | 12 | M11318 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 6.78e-07 | 164 | 204 | 10 | M19957 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NUSAP1 EPRS1 ATR FAM13B SACS KIF14 ITM2A NIPBL USP47 KNL1 KIF23 NAA15 ZNF407 UFL1 XPO1 SMC2 ARHGAP5 ATM PUS7L | 1.02e-06 | 656 | 204 | 19 | M18979 |
| Coexpression | WINTER_HYPOXIA_DN | 3.12e-06 | 52 | 204 | 6 | M2683 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 3.56e-06 | 197 | 204 | 10 | M3136 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | SPTAN1 SNRK PCNX2 TSC22D1 PAN2 ARHGEF6 USP47 SYNE1 HECTD4 METTL9 | 3.90e-06 | 199 | 204 | 10 | M7607 |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP | EPRS1 TSC22D1 GCLC CLNS1A PAN2 ITM2A NAA15 DDX60 HDDC2 TPT1P8 | 4.08e-06 | 200 | 204 | 10 | M4488 |
| Coexpression | FISCHER_DREAM_TARGETS | NUSAP1 STAG1 FANCA FANCD2 NUFIP2 KIF14 DSCC1 NIPBL KNL1 KIF23 NAA15 NSD2 USP28 CIP2A XRCC2 METTL4 USP37 SMC2 CCNB1 ABCE1 DZIP3 THAP12 | 7.46e-06 | 969 | 204 | 22 | M149 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | ATR ERAP1 ARL5A SACS CLK1 CLNS1A NME1 USP47 NAA16 NAA15 DDX60 HDDC2 UFL1 ARHGAP5 USO1 ABCE1 ATM PCMT1 | 7.92e-06 | 687 | 204 | 18 | M41022 |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.09e-05 | 177 | 204 | 9 | M7632 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | NUSAP1 TPR EPRS1 ATR FANCD2 FBXO22 KIF14 NME1 USP47 KNL1 PNP NAA15 CIP2A SMC2 CCNB1 ARL5B ABCE1 | 1.30e-05 | 644 | 204 | 17 | M10501 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NUSAP1 STAG1 ABCB1 FANCA FANCD2 DSCC1 KNL1 KIF23 NSD2 CIP2A XPO1 XRCC2 SMC2 CCNB1 SERTAD4 THAP12 | 1.32e-05 | 578 | 204 | 16 | M2368 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 CCDC122 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A SMC2 CCNB1 SLC4A4 | 1.76e-05 | 402 | 204 | 13 | MM454 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | NUSAP1 FAM13B TSC22D1 GCLC NIPBL KIF23 CIP2A XPO1 SMC2 CCNB1 | 1.80e-05 | 237 | 204 | 10 | M15606 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.92e-05 | 190 | 204 | 9 | M761 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NUSAP1 STAG1 ABCB1 FANCA FANCD2 DSCC1 KNL1 KIF23 NSD2 CIP2A XPO1 XRCC2 SMC2 CCNB1 SERTAD4 THAP12 | 1.95e-05 | 597 | 204 | 16 | MM1309 |
| Coexpression | GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP | STAG1 KIAA0232 PCNX2 PDZK1P1 ZNF407 NR3C1 USP37 ARHGAP5 DZIP3 | 2.26e-05 | 194 | 204 | 9 | M8282 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NUSAP1 RNF112 RRAGB FANCA FANCD2 KIF14 NME1 WNK2 KNL1 DOCK3 KIF23 SLC4A8 NSD2 USP37 SMC2 CCNB1 SERTAD4 | 2.59e-05 | 680 | 204 | 17 | MM456 |
| Coexpression | GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.65e-05 | 198 | 204 | 9 | M7200 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 2.76e-05 | 199 | 204 | 9 | M7779 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 2.76e-05 | 199 | 204 | 9 | M9253 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.87e-05 | 200 | 204 | 9 | M5041 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | NUSAP1 ERAP1 ARL5A PLAU DSCC1 KNL1 KIF23 DDX60 XPO1 ADAM22 PUS7L | 2.94e-05 | 305 | 204 | 11 | M19875 |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 3.48e-05 | 158 | 204 | 8 | MM3851 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | TPR TPT1 SNX3 GCLC SCO1 NME1 HDAC6 COPS3 ARPC4 ADAM22 MST1R USO1 ABCE1 RRAGA ATM MAPK7 THAP12 PCMT1 | 3.91e-05 | 775 | 204 | 18 | M17753 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 4.35e-05 | 163 | 204 | 8 | M8235 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ATR STAG1 NCKAP1 TRIO AVL9 TSC22D2 SACS KIF14 DENND5A CLEC16A NIPBL KIF23 XPO1 NR3C1 TRAK1 IGF2R ABCE1 PCMT1 | 4.37e-05 | 856 | 204 | 19 | M4500 |
| Coexpression | FIRESTEIN_PROLIFERATION | 4.95e-05 | 166 | 204 | 8 | M5354 | |
| Coexpression | BENPORATH_CYCLING_GENES | NUSAP1 STAG1 INSR FANCA FANCD2 TSC22D1 KIF14 DSCC1 NIPBL KIF23 DSP CIP2A NR3C1 CCNB1 LMNA DZIP3 | 5.21e-05 | 648 | 204 | 16 | M8156 |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 5.43e-05 | 27 | 204 | 4 | M2483 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 6.30e-05 | 28 | 204 | 4 | MM1323 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C2 | 6.31e-05 | 54 | 204 | 5 | M2589 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | NUSAP1 TPR EPRS1 PSMC3 RPL10A FANCD2 CLNS1A EIF3L SLITRK6 NME1 KNL1 KIF23 KRT16 DSP COPS3 SMC2 CCNB1 METTL9 PCMT1 | 7.43e-05 | 891 | 204 | 19 | M41654 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | EPRS1 AVL9 ERAP1 TSC1 TLR7 ABCB1 TSC22D1 SACS CLK1 NIPBL HSPA5 CCZ1B XPO1 NR3C1 PRPF8 ADAM22 TRAK1 CCZ1 ZNF277 DZIP3 ATM ADI1 PCMT1 | 7.90e-05 | 1215 | 204 | 23 | M41122 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.74e-05 | 180 | 204 | 8 | M8239 | |
| Coexpression | DANG_BOUND_BY_MYC | SNX3 INSR GCLC SCO1 NME1 AMPD2 HDAC6 COPS3 ARPC4 ADAM22 CCNB1 TGFB1 MST1R LMNA USO1 RRAGA PAPPA ATM MAPK7 THAP12 PCMT1 | 8.86e-05 | 1061 | 204 | 21 | M15774 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 9.84e-05 | 290 | 204 | 10 | M45736 | |
| Coexpression | MTOR_UP.N4.V1_DN | 1.02e-04 | 184 | 204 | 8 | M2756 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 1.02e-04 | 184 | 204 | 8 | M9988 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | NUSAP1 EPRS1 ATR ARL5A FBXO22 SACS PAN2 KIF14 PLAU NME1 DSCC1 KNL1 KIF23 NAA15 FNTA NSD2 DDX60 CIP2A XPO1 SMC2 ADAM22 CCNB1 CCZ1 ABCE1 PUS7L | 1.04e-04 | 1407 | 204 | 25 | M14427 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 1.12e-04 | 139 | 204 | 7 | M9006 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 1.14e-04 | 187 | 204 | 8 | M6807 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 1.17e-04 | 240 | 204 | 9 | MM976 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 1.22e-04 | 33 | 204 | 4 | M1490 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 1.38e-04 | 34 | 204 | 4 | MM1160 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | NUSAP1 TPR TRIO KIAA0232 SPTAN1 BCOR NEK3 TSC22D1 SACS KIF14 DENND5A DDX60 UFL1 IGF2R ATM ADI1 PCMT1 | 1.61e-04 | 790 | 204 | 17 | M12490 |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN | 1.63e-04 | 197 | 204 | 8 | M6152 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | ERAP1 TSC22D1 FBXO22 ANKRD12 ITM2A USP47 KALRN NR3C1 IGF2R PAPPA | 1.65e-04 | 309 | 204 | 10 | M1973 |
| Coexpression | GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP | 1.69e-04 | 198 | 204 | 8 | M4539 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP | 1.69e-04 | 198 | 204 | 8 | M5044 | |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_UP | NUSAP1 SPTAN1 FANCD2 KIF14 NME1 DSCC1 KNL1 NSD2 ARPC4 CCNB1 ARL5B GUCY2C | 1.71e-04 | 436 | 204 | 12 | M18855 |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_DN | 1.74e-04 | 253 | 204 | 9 | M16010 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN | 1.75e-04 | 199 | 204 | 8 | M4670 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.75e-04 | 199 | 204 | 8 | M5893 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_DC_UP | 1.75e-04 | 199 | 204 | 8 | M5399 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 1.75e-04 | 199 | 204 | 8 | M5486 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.75e-04 | 199 | 204 | 8 | M4444 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 1.75e-04 | 199 | 204 | 8 | M5682 | |
| Coexpression | GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.81e-04 | 200 | 204 | 8 | M5338 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.81e-04 | 200 | 204 | 8 | M5901 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP | 1.81e-04 | 200 | 204 | 8 | M6713 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP | 1.81e-04 | 200 | 204 | 8 | M9293 | |
| Coexpression | HOLLMANN_APOPTOSIS_VIA_CD40_UP | 2.00e-04 | 203 | 204 | 8 | M9695 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.03e-04 | 153 | 204 | 7 | M5588 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_DN | 2.19e-04 | 320 | 204 | 10 | M10279 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.20e-04 | 155 | 204 | 7 | MM1259 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.20e-04 | 155 | 204 | 7 | M39041 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ACP6 TPR ERAP1 VPS33A GIT2 ABCB1 CCDC13 KLHL13 CLNS1A ACCS DSCC1 SULT4A1 SPDYE4 USP47 KRT16 FNTA VPS26B POR XPO4 PCMT1 AP3S2 | 2.26e-04 | 1136 | 204 | 21 | M2247 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | NUSAP1 FANCA TTLL12 GCLC KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A SMC2 CCNB1 | 2.28e-04 | 450 | 204 | 12 | M45747 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.36e-04 | 323 | 204 | 10 | M2156 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 2.37e-04 | 111 | 204 | 6 | M7357 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | NUSAP1 STAG1 FANCD2 SACS PAN2 KIF14 HDAC6 NSD2 XRCC2 CCNB1 METTL9 THAP12 | 2.47e-04 | 454 | 204 | 12 | M19927 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | NUSAP1 ATR STAG1 DOCK11 FAM13B ARL5A NIPBL NAA15 CIP2A XPO1 NR3C1 ARHGAP5 ZNF277 | 2.48e-04 | 523 | 204 | 13 | M12707 |
| Coexpression | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN | 2.49e-04 | 72 | 204 | 5 | M170 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 2.59e-04 | 267 | 204 | 9 | M41130 | |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 2.88e-04 | 162 | 204 | 7 | M6387 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | NUSAP1 ATR STAG1 DOCK11 FAM13B ARL5A NIPBL NAA15 CIP2A XPO1 NR3C1 ARHGAP5 ZNF277 | 3.03e-04 | 534 | 204 | 13 | MM1054 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NUSAP1 EPRS1 FANCA RPL10A CLNS1A EIF3L KIF14 NME1 KIF23 FNTA NSD2 GPS1 SMC2 CCNB1 | 3.35e-04 | 612 | 204 | 14 | M4772 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TRIO ARL5A ABCB1 TTLL12 C1QTNF3 ANKRD12 DSP DLGAP4 IGF2R ATM PCMT1 LARGE1 | 3.71e-04 | 475 | 204 | 12 | M40979 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XPO1 METTL4 USP37 SMC2 ZDHHC4 CCNB1 | 3.75e-04 | 694 | 204 | 15 | M45767 |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | TPT1 TSC22D1 CDC40 CLEC16A ITM2A DNAH3 KIF23 KRT16 ARHGEF12 NR3C1 PCMT1 | 4.02e-04 | 411 | 204 | 11 | M1047 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NUSAP1 EPRS1 STAG1 INSR FANCA FANCD2 FBXO22 KIF14 NME1 DSCC1 KNL1 PNP CCZ1B KIF23 IKZF2 NAA15 NSD2 CIP2A XPO1 METTL4 SMC2 CCNB1 ADI1 | 4.15e-04 | 1363 | 204 | 23 | M45782 |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_UP | 4.50e-04 | 46 | 204 | 4 | M4888 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ACP6 TPR ERAP1 VPS33A GIT2 ABCB1 CCDC13 KLHL13 CLNS1A ACCS DSCC1 SULT4A1 SPDYE4 USP47 KRT16 FNTA VPS26B POR XPO4 PCMT1 AP3S2 | 4.57e-04 | 1198 | 204 | 21 | MM1062 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 4.69e-04 | 126 | 204 | 6 | M9362 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | NUSAP1 ATR STAG1 PSMC3 FANCA FANCD2 FBXO22 KLHL13 KIF14 USP47 KNL1 KIF23 FNTA NSD2 XPO4 COPS3 METTL4 USP37 SMC2 CCNB1 CCZ1 CDH12 | 4.83e-04 | 1290 | 204 | 22 | M80 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 5.24e-04 | 179 | 204 | 7 | M3268 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 5.48e-04 | 236 | 204 | 8 | M130 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 5.60e-04 | 181 | 204 | 7 | M2641 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 5.79e-04 | 182 | 204 | 7 | M8126 | |
| Coexpression | ZHONG_PFC_C1_OPC | 5.79e-04 | 238 | 204 | 8 | M39096 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | SNX3 SPTBN2 PSMC3 ARL5A TSC22D1 GCLC CLNS1A NME1 ITM2A FAM8A1 PNP HDAC6 FNTA COPS3 XPO1 SMC2 TGFB1 LMNA ZNF277 ABCE1 RRAGA THAP12 PCMT1 | 5.94e-04 | 1399 | 204 | 23 | M535 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 6.04e-04 | 300 | 204 | 9 | M45675 | |
| Coexpression | ZHOU_TNF_SIGNALING_4HR | 6.20e-04 | 50 | 204 | 4 | M1520 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 6.46e-04 | 242 | 204 | 8 | M2128 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 6.63e-04 | 243 | 204 | 8 | M14072 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 6.75e-04 | 135 | 204 | 6 | MM753 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DYM ATR SPTBN2 RRAGB FANCD2 NEK3 FBXO22 GCLC KIF14 DSCC1 NAA16 DOCK3 NAA15 DSP NSD2 USP28 CIP2A CECR2 XPO4 METTL4 USP37 ADAM22 CCNB1 DROSHA DZIP3 ATM | 4.87e-08 | 822 | 197 | 26 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | DYM RRAGB FANCD2 NEK3 GCLC KIF14 NAA16 CIP2A CECR2 METTL4 USP37 DROSHA ATM | 1.30e-06 | 266 | 197 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DYM ATR SPTAN1 TSC1 FANCD2 NEK3 FBXO22 GCLC KIF14 ANKRD12 NAA16 DOCK3 USP28 CIP2A CECR2 XPO4 METTL4 ADAM22 CCNB1 DROSHA DZIP3 ATM | 6.76e-06 | 810 | 197 | 22 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DYM ATR AVL9 RRAGB FANCD2 NEK3 GCLC KIF14 ANKRD12 DSCC1 NAA16 DOCK3 KIF23 DSP USP28 CIP2A CECR2 METTL4 USP37 ADAM22 DZIP3 ATM | 8.20e-06 | 820 | 197 | 22 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NUSAP1 EFCAB5 TPR SPTAN1 SPTBN2 TSC1 BCOR KLHL13 KIF14 ZNF606 NIPBL WNK2 KNL1 DOCK3 FAM184A SLC4A8 HDAC6 NSD2 USP28 CEP162 CIP2A DLGAP4 POR XRCC2 METTL4 USP37 SMC2 TRAK1 ATM PRDM16 | 9.99e-06 | 1370 | 197 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | NUSAP1 TLR7 FANCD2 TSC22D1 KIF14 DSCC1 KNL1 PNP KIF23 NSD2 CIP2A CECR2 CPA3 SMC2 DZIP3 | 1.00e-05 | 422 | 197 | 15 | GSM538355_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | NUSAP1 FANCD2 MPP4 KIF14 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 PRDM16 | 1.09e-05 | 373 | 197 | 14 | GSM605781_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | NUSAP1 TPR SYCP2L DOCK11 INSR FANCA TTLL12 TMEM132C SLITRK6 SPDYE4 NIPBL KNL1 PNP SYNE1 CECR2 ARHGEF12 POR SMC2 GTF2IRD1 ADAM22 ARHGAP5 PRDM16 PCMT1 AP3S2 | 1.65e-05 | 989 | 197 | 24 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | NUSAP1 FANCD2 MPP4 KIF14 DSCC1 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 | 3.44e-05 | 414 | 197 | 14 | GSM476660_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | DYM ATR RRAGB FANCD2 NEK3 GCLC DSCC1 NAA16 KIF23 CIP2A METTL4 USP37 ATM | 3.47e-05 | 361 | 197 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | NUSAP1 TRIO TTLL12 MPP4 KIF14 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 | 4.35e-05 | 423 | 197 | 14 | GSM476655_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NUSAP1 TPR FANCD2 PTPRO KLHL13 KIF14 ZNF606 NIPBL WNK2 KNL1 FAM184A SLC4A8 TTC41P NSD2 USP28 CEP162 CIP2A XRCC2 SMC2 CCNB1 ARHGAP5 PAPPA ATM PRDM16 | 5.01e-05 | 1060 | 197 | 24 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | DYM ATR SPTBN2 RRAGB FANCD2 NEK3 FBXO22 GCLC KIF14 NAA16 USP28 CIP2A CECR2 XPO4 SCGN METTL4 USP37 CCNB1 DROSHA ATM | 5.33e-05 | 795 | 197 | 20 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | DYM FANCD2 NEK3 GCLC KIF14 NAA16 USP28 CIP2A CECR2 METTL4 DROSHA ATM | 6.91e-05 | 333 | 197 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | NUSAP1 TPR EPRS1 TRIO ARL5A CLK1 DSCC1 KNL1 CIP2A DLGAP4 ZNF407 XPO1 GTF2IRD1 ARHGAP5 CCZ1 DZIP3 | 7.80e-05 | 564 | 197 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | NUSAP1 KIF14 ITM2A KNL1 AKAP6 KIF23 IKZF2 DDX60 CIP2A SMC2 GTF2IRD1 GPR68 PUS7L | 9.34e-05 | 398 | 197 | 13 | GSM538338_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | NUSAP1 MPP4 KIF14 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 | 1.08e-04 | 349 | 197 | 12 | GSM476675_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NUSAP1 TPR SYCP2L ABCB1 FANCD2 PTPRO KLHL13 KIF14 ZNF606 NIPBL WNK2 KNL1 DOCK3 FAM184A SLC4A8 TTC41P NSD2 USP28 CEP162 CIP2A CECR2 XRCC2 SMC2 CCNB1 ARHGAP5 PAPPA ATM PRDM16 | 1.18e-04 | 1414 | 197 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | NUSAP1 TTLL12 MPP4 KIF14 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 | 1.32e-04 | 412 | 197 | 13 | GSM605793_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | NUSAP1 FANCD2 MPP4 KIF14 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 GTF2IRD1 | 1.67e-04 | 422 | 197 | 13 | GSM476658_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | NUSAP1 TLR7 FANCD2 TSC22D1 KIF14 DSCC1 KNL1 PNP KIF23 NSD2 CIP2A CECR2 SMC2 | 1.67e-04 | 422 | 197 | 13 | GSM538357_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 1.81e-04 | 89 | 197 | 6 | GSM476660_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NUSAP1 TPR SYCP2L ATR TLR7 FANCD2 ZNF606 DSCC1 NIPBL KNL1 NAA16 DOCK3 FAM184A SLC4A8 TTC41P NSD2 CIP2A CECR2 UFL1 XPO1 SMC2 CCNB1 ARHGAP5 TADA2B DZIP3 PAPPA ATM PRDM16 | 2.00e-04 | 1459 | 197 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | NUSAP1 TPR FANCA TMEM132C SLITRK6 SPDYE4 NIPBL KNL1 SYNE1 POR SMC2 GTF2IRD1 ARHGAP5 | 2.09e-04 | 432 | 197 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | NUSAP1 FANCD2 TTLL12 DSCC1 ITM2A KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 GTF2IRD1 | 2.15e-04 | 376 | 197 | 12 | GSM791154_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NUSAP1 TPR ATR TLR7 FANCD2 ZNF606 DSCC1 NIPBL KNL1 NAA16 FAM184A SLC4A8 TTC41P NSD2 CIP2A UFL1 XPO1 SMC2 CCNB1 ARHGAP5 TADA2B DZIP3 PAPPA ATM PRDM16 | 2.65e-04 | 1257 | 197 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | NUSAP1 TLR7 FANCD2 TSC22D1 KIF14 KNL1 PNP KIF23 NSD2 CIP2A CECR2 SMC2 | 2.86e-04 | 388 | 197 | 12 | GSM538352_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.09e-04 | 230 | 197 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | NUSAP1 PIK3AP1 FANCD2 GCLC KIF14 KNL1 KIF23 NSD2 CIP2A CECR2 SMC2 SERTAD4 | 3.37e-04 | 395 | 197 | 12 | GSM538340_500 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | NUSAP1 TLR7 ITM2A KNL1 KIF23 IKZF2 DDX60 CIP2A SMC2 GTF2IRD1 ATM | 3.42e-04 | 339 | 197 | 11 | GSM399382_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | NUSAP1 FANCD2 TTLL12 KIF14 DSCC1 KNL1 KIF23 IKZF2 NSD2 CIP2A METTL4 SMC2 | 3.52e-04 | 397 | 197 | 12 | GSM791143_500 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | NUSAP1 PIK3AP1 ACP6 FANCD2 KIF14 KNL1 KIF23 NSD2 CIP2A CECR2 SMC2 SERTAD4 | 3.85e-04 | 401 | 197 | 12 | GSM399450_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | NUSAP1 NCKAP1 ABCB1 FANCD2 KIF14 KNL1 KIF23 NSD2 CIP2A SMC2 IGF2R GPR68 | 3.94e-04 | 402 | 197 | 12 | GSM605898_500 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | RRAGB KIF14 DSCC1 KNL1 NAA15 CIP2A CECR2 SMC2 CCNB1 ARL5B THAP12 | 4.27e-04 | 348 | 197 | 11 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MAOB TRIO DOCK11 TSC1 GIT2 SULT1E1 TMEM132C C1QTNF3 ANKRD12 SLITRK6 ITM2A KNL1 XPO4 SMC2 ARL5B LMNA DZIP3 DCLK3 | 4.85e-04 | 799 | 197 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | NUSAP1 TLR7 FANCD2 TSC22D1 KIF14 KNL1 PNP KIF23 CIP2A CECR2 CPA3 SMC2 | 5.57e-04 | 418 | 197 | 12 | GSM538350_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.69e-04 | 110 | 197 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | NUSAP1 FANCD2 TSC22D1 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A CECR2 CPA3 SMC2 | 5.69e-04 | 419 | 197 | 12 | GSM538348_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | NUSAP1 NCKAP1 FANCD2 KIF14 KNL1 KIF23 IKZF2 DSP NSD2 CIP2A SMC2 GPR68 | 5.69e-04 | 419 | 197 | 12 | GSM476664_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | NUSAP1 FANCD2 TSC22D1 KIF14 DSCC1 KNL1 KIF23 IKZF2 NSD2 CIP2A CPA3 SMC2 | 5.81e-04 | 420 | 197 | 12 | GSM791141_500 |
| CoexpressionAtlas | e8.5_NeuroEpith_nonFloorPlate_top-relative-expression-ranked_500 | SYCP2L MAOB ARL5A FBXO22 GCLC SCO1 SULT4A1 NAA16 WDR48 HDAC6 CIP2A DROSHA | 6.32e-04 | 424 | 197 | 12 | Facebase_ST1_e8.5_NeuroEpith_nonFloorPlate_500 |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | NUSAP1 TRIO TTLL12 KIF14 KNL1 KIF23 IKZF2 NSD2 CIP2A HECTD4 GTF2IRD1 | 6.63e-04 | 367 | 197 | 11 | GSM399391_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | SYCP2L FANCA TMEM132C SLITRK6 NIPBL SLC4A8 CECR2 ARHGEF12 HDDC2 SMC2 GTF2IRD1 PRDM16 AP3S2 | 7.17e-04 | 492 | 197 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | 11c3d9fe811a4619347f47d2b0e94066e3085625 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.49e-10 | 199 | 204 | 12 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NUSAP1 FANCA FANCD2 KIF14 KNL1 KRT16 NSD2 CIP2A XRCC2 CCNB1 DCLK3 | 5.36e-10 | 174 | 204 | 11 | 84da9faff088d05233183b425385beb054c92d1b |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | NUSAP1 FANCA FANCD2 KIF14 KNL1 KIF23 KRT16 NSD2 CIP2A CCNB1 DCLK3 | 5.36e-10 | 174 | 204 | 11 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | NUSAP1 FANCA FANCD2 KIF14 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.03e-09 | 185 | 204 | 11 | 9766216b41ee62bbac4caa25cb98ec5627a24075 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 CIP2A XRCC2 SMC2 CCNB1 | 1.79e-09 | 195 | 204 | 11 | 926eb3fc5d028be936885bea0654a77db3107234 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | NUSAP1 FANCA FANCD2 KIF14 DSCC1 KNL1 KIF23 CIP2A XRCC2 SMC2 CCNB1 | 1.79e-09 | 195 | 204 | 11 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | d7a9296092153cf66426911fecd810f0c1ef978e |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | dcff23240bb7cb652d7426b29355aa74442ef6fc |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | 434a5686a103bb766e0d80038413f0e12ea3981a |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | 794517c70089da109f4c6489fe406c0ba6882b76 |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | c0a71a9452febda433bc544e4ac0a79c43dcf13e |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 1.99e-09 | 197 | 204 | 11 | f34b1e34f1f0694564031077172c890b233ce8b7 |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | NUSAP1 FANCD2 KIF14 DSCC1 KNL1 KIF23 NSD2 CIP2A XRCC2 SMC2 CCNB1 | 2.22e-09 | 199 | 204 | 11 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b |
| ToppCell | severe-Lymphocytic-Prol._cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | NUSAP1 KIF14 NME1 DSCC1 ITM2A KNL1 KIF23 NSD2 CIP2A SMC2 CCNB1 | 2.22e-09 | 199 | 204 | 11 | b24315952b6ac6c8d2d3a7bd949a5b5392624d4e |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NUSAP1 TTLL12 KIF14 DSCC1 KNL1 FAM184A KIF23 SMC2 CCNB1 GPR68 | 7.44e-09 | 172 | 204 | 10 | e495efd25aec60b97ac2b5aa861651bd73174a17 |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | KIF14 DSCC1 KNL1 KIF23 XRCC2 SMC2 ADAM22 CCNB1 NBPF10 LARGE1 | 9.80e-09 | 177 | 204 | 10 | 844017225e9039d1bc621a9630a30c2e9a51b36d |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-08 | 180 | 204 | 10 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-08 | 189 | 204 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.93e-08 | 190 | 204 | 10 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-08 | 142 | 204 | 9 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.23e-08 | 193 | 204 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.46e-08 | 195 | 204 | 10 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-08 | 195 | 204 | 10 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.46e-08 | 195 | 204 | 10 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-08 | 195 | 204 | 10 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.59e-08 | 196 | 204 | 10 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.59e-08 | 196 | 204 | 10 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.59e-08 | 196 | 204 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.71e-08 | 197 | 204 | 10 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.71e-08 | 197 | 204 | 10 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.71e-08 | 197 | 204 | 10 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ALDH1L1 CFAP100 FHAD1 CC2D2A CIBAR2 CFAP47 DNAH3 SYNE1 DZIP3 CFAP157 | 2.71e-08 | 197 | 204 | 10 | 91637bdeab85024b5a02d1066f76cb803a2d6420 |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 2.71e-08 | 197 | 204 | 10 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.71e-08 | 197 | 204 | 10 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.85e-08 | 198 | 204 | 10 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 2.85e-08 | 198 | 204 | 10 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 2.85e-08 | 198 | 204 | 10 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | TSNAXIP1 INSR CCDC122 CFAP100 FHAD1 CIBAR2 DNAH3 CCDC148 IQCA1 CFAP157 | 2.85e-08 | 198 | 204 | 10 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 2.85e-08 | 198 | 204 | 10 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.85e-08 | 198 | 204 | 10 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-08 | 198 | 204 | 10 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 2.99e-08 | 199 | 204 | 10 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.99e-08 | 199 | 204 | 10 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 2.99e-08 | 199 | 204 | 10 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 2.99e-08 | 199 | 204 | 10 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.99e-08 | 199 | 204 | 10 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 2.99e-08 | 199 | 204 | 10 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 2.99e-08 | 199 | 204 | 10 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.99e-08 | 199 | 204 | 10 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.99e-08 | 199 | 204 | 10 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.99e-08 | 199 | 204 | 10 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.99e-08 | 199 | 204 | 10 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.13e-08 | 200 | 204 | 10 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.13e-08 | 200 | 204 | 10 | 1da366e35a05f73253629663eeea1fed4ebd7b52 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.13e-08 | 200 | 204 | 10 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.13e-08 | 200 | 204 | 10 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.13e-08 | 200 | 204 | 10 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.13e-08 | 200 | 204 | 10 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.13e-08 | 200 | 204 | 10 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.13e-08 | 200 | 204 | 10 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.13e-08 | 200 | 204 | 10 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | 55501f83409e0174c756a13ad8077f5b59975e27 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | b9aad527d3ad5bc701e93fa2afdebf695b2a74bb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.13e-08 | 200 | 204 | 10 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-08 | 164 | 204 | 9 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-08 | 166 | 204 | 9 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-08 | 168 | 204 | 9 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-08 | 169 | 204 | 9 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-07 | 175 | 204 | 9 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-07 | 177 | 204 | 9 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-07 | 179 | 204 | 9 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-07 | 180 | 204 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 1.63e-07 | 181 | 204 | 9 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 1.63e-07 | 181 | 204 | 9 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.70e-07 | 182 | 204 | 9 | 9adf90bb2808f234d53b89ca0ae07380478204ad | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.79e-07 | 183 | 204 | 9 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.87e-07 | 184 | 204 | 9 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-07 | 185 | 204 | 9 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | TSNAXIP1 CFAP100 FHAD1 CCDC13 CC2D2A AKAP6 CFAP47 DNAH3 CFAP157 | 1.96e-07 | 185 | 204 | 9 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| Drug | alsterpaullone | 6.28e-07 | 35 | 204 | 6 | CID005005498 | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | TRIO FANCA NEK3 FAM118A DNAH3 ARHGEF12 POR LMNA ZNF277 DZIP3 MAPK7 | 1.58e-06 | 195 | 204 | 11 | 6626_DN |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; PC3; HG-U133A | TPT1 NCKAP1 TSC22D2 GCLC NAA16 WDR48 ARHGEF12 NR3C1 IGF2R LMNA PCMT1 | 1.58e-06 | 195 | 204 | 11 | 1934_DN |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; MCF7; HG-U133A | ATR GIT2 CLK1 NR3C1 ARPC4 ADAM22 TRAK1 ARHGAP5 DZIP3 PCMT1 PUS7L | 1.75e-06 | 197 | 204 | 11 | 202_UP |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | TRIO SPTAN1 GIT2 NEK3 FAM118A WDR48 ARHGEF12 ADAM22 TRAK1 ATM MAPK7 | 1.84e-06 | 198 | 204 | 11 | 4979_DN |
| Drug | Latex | 9.19e-06 | 191 | 204 | 10 | ctd:D007840 | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | TRIO AVL9 KIAA0232 SPTAN1 SNRK RYR2 PLAU DLGAP4 ARHGEF12 NR3C1 | 9.19e-06 | 191 | 204 | 10 | 2771_UP |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | VPS33A RYR2 FANCA TMCO3 ZNF606 AMPD2 DLGAP4 ARHGEF12 TRAK1 MAPK7 | 1.10e-05 | 195 | 204 | 10 | 2125_DN |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | MAOB RYR1 SULT4A1 ARHGEF6 SYNE1 ARHGEF12 NR3C1 ADAM22 TRAK1 DZIP3 | 1.20e-05 | 197 | 204 | 10 | 3299_UP |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; HL60; HG-U133A | 1.20e-05 | 197 | 204 | 10 | 1441_UP | |
| Disease | hippocampus molecular layer volume | 3.56e-06 | 35 | 198 | 5 | EFO_0009397 | |
| Disease | renal cell carcinoma (is_marker_for) | 2.62e-05 | 128 | 198 | 7 | DOID:4450 (is_marker_for) | |
| Disease | PR interval | EFCAB5 ALDH1L1 TSC22D2 RYR2 COQ8A AKAP6 KALRN USP28 XPO4 METTL4 ADAM22 TRAK1 THAP12 | 3.30e-05 | 495 | 198 | 13 | EFO_0004462 |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 3.45e-05 | 10 | 198 | 3 | DOID:0050431 (is_implicated_in) | |
| Disease | Myocardial Infarction | 4.48e-05 | 95 | 198 | 6 | C0027051 | |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 4.48e-05 | 2 | 198 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | TPT1 ATR SULT1E1 PLAU HDAC6 USP28 XPO1 NR3C1 TGFB1 IGF2R USO1 ATM ADI1 CDH12 | 7.82e-05 | 616 | 198 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | TPT1 ATR SULT1E1 PLAU HDAC6 USP28 XPO1 NR3C1 TGFB1 IGF2R USO1 ATM ADI1 CDH12 | 7.82e-05 | 616 | 198 | 14 | C0376358 |
| Disease | Colorectal Carcinoma | NUSAP1 SPTBN2 ALDH1L1 ABCB1 SACS PAN2 NME1 AKAP6 DNAH3 KALRN SYNE1 TGFB1 CCNB3 GUCY2C ABCE1 | 8.63e-05 | 702 | 198 | 15 | C0009402 |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.03e-04 | 14 | 198 | 3 | DOID:3753 (implicated_via_orthology) | |
| Disease | anemia (implicated_via_orthology) | 1.28e-04 | 15 | 198 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.28e-04 | 15 | 198 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Myocardial Preinfarction Syndrome | 1.34e-04 | 3 | 198 | 2 | C0086666 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | anorexia nervosa (is_implicated_in) | 1.34e-04 | 3 | 198 | 2 | DOID:8689 (is_implicated_in) | |
| Disease | Angina, Unstable | 1.34e-04 | 3 | 198 | 2 | C0002965 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | X-24422 measurement | 1.34e-04 | 3 | 198 | 2 | EFO_0800880 | |
| Disease | chronic obstructive pulmonary disease (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:3083 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.49e-04 | 40 | 198 | 4 | C0598589 | |
| Disease | Liver carcinoma | NUSAP1 TSC1 ABCB1 FANCD2 KIF14 NME1 HSPA5 KIF23 CCNB1 TGFB1 IGF2R ATM | 1.76e-04 | 507 | 198 | 12 | C2239176 |
| Disease | Meckel syndrome type 1 | 2.25e-04 | 18 | 198 | 3 | C3714506 | |
| Disease | breast cancer (is_marker_for) | 2.64e-04 | 185 | 198 | 7 | DOID:1612 (is_marker_for) | |
| Disease | Hematopoietic Neoplasms | 2.66e-04 | 4 | 198 | 2 | C0376544 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.66e-04 | 4 | 198 | 2 | cv:CN293514 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 2.80e-04 | 47 | 198 | 4 | DOID:783 (biomarker_via_orthology) | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.58e-04 | 90 | 198 | 5 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Infiltrating duct carcinoma of female breast | 3.62e-04 | 21 | 198 | 3 | C3165106 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.42e-04 | 5 | 198 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.42e-04 | 5 | 198 | 2 | C0410190 | |
| Disease | ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 | 4.42e-04 | 5 | 198 | 2 | C1832931 | |
| Disease | breast cancer (is_implicated_in) | 5.44e-04 | 150 | 198 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | Fanconi Anemia | 6.14e-04 | 25 | 198 | 3 | C0015625 | |
| Disease | Brain Diseases | 6.14e-04 | 25 | 198 | 3 | C0006111 | |
| Disease | fibrinogen measurement, coronary artery disease | 6.24e-04 | 154 | 198 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | obesity (implicated_via_orthology) | 6.50e-04 | 215 | 198 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.60e-04 | 6 | 198 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.60e-04 | 6 | 198 | 2 | C0410189 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 6.71e-04 | 59 | 198 | 4 | EFO_0001663, MONDO_0005148 | |
| Disease | Acute monocytic leukemia | 6.90e-04 | 26 | 198 | 3 | C0023465 | |
| Disease | Encephalopathies | 7.73e-04 | 27 | 198 | 3 | C0085584 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.20e-04 | 7 | 198 | 2 | C0751337 | |
| Disease | Intellectual Disability | 9.34e-04 | 447 | 198 | 10 | C3714756 | |
| Disease | Miller Dieker syndrome | 9.56e-04 | 29 | 198 | 3 | C0265219 | |
| Disease | breast carcinoma (is_marker_for) | 1.02e-03 | 66 | 198 | 4 | DOID:3459 (is_marker_for) | |
| Disease | factor XI measurement, venous thromboembolism | 1.06e-03 | 30 | 198 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | intellectual disability (is_implicated_in) | 1.06e-03 | 30 | 198 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 1.22e-03 | 8 | 198 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Sudden Cardiac Arrest | 1.22e-03 | 8 | 198 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 1.22e-03 | 8 | 198 | 2 | C0085298 | |
| Disease | coffee consumption | 1.28e-03 | 32 | 198 | 3 | EFO_0004330 | |
| Disease | female fertility, fertility measurement | 1.40e-03 | 33 | 198 | 3 | EFO_0006918, EFO_0006923 | |
| Disease | orthostatic hypotension | 1.56e-03 | 9 | 198 | 2 | EFO_0005252 | |
| Disease | Endomyocardial Fibrosis | 1.56e-03 | 9 | 198 | 2 | C0553980 | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 1.56e-03 | 9 | 198 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.95e-03 | 10 | 198 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | eotaxin measurement | 2.09e-03 | 80 | 198 | 4 | EFO_0008122 | |
| Disease | cataract (implicated_via_orthology) | 2.11e-03 | 38 | 198 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 2.29e-03 | 82 | 198 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.29e-03 | 82 | 198 | 4 | C0751111 | |
| Disease | Aura | 2.29e-03 | 82 | 198 | 4 | C0236018 | |
| Disease | Liver Cirrhosis, Experimental | ERAP1 SPTAN1 ALDH1L1 ABCB1 SULT1E1 TSC22D1 PTPRO PLAU SMC2 TGFB1 IGF2R GPR68 SLC4A4 | 2.31e-03 | 774 | 198 | 13 | C0023893 |
| Disease | ovary epithelial cancer (is_implicated_in) | 2.37e-03 | 11 | 198 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | Tachycardia, Ventricular | 2.37e-03 | 11 | 198 | 2 | C0042514 | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | Enzymopathy | 2.37e-03 | 11 | 198 | 2 | C0520572 | |
| Disease | Kidney Neoplasm | 2.45e-03 | 40 | 198 | 3 | C0022665 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.52e-03 | 139 | 198 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 2.52e-03 | 139 | 198 | 5 | C0007621 | |
| Disease | Bladder Neoplasm | 2.60e-03 | 140 | 198 | 5 | C0005695 | |
| Disease | Parkinson Disease | 2.61e-03 | 85 | 198 | 4 | C0030567 | |
| Disease | hippocampal CA4 volume | 2.63e-03 | 41 | 198 | 3 | EFO_0009396 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.63e-03 | 41 | 198 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Schizophrenia | TPT1 DYM MAOB SPTBN2 ABCB1 GCLC NUFIP2 SULT4A1 MOG GPS1 NR3C1 TRAK1 TGFB1 ATM | 2.67e-03 | 883 | 198 | 14 | C0036341 |
| Disease | Malignant neoplasm of urinary bladder | 2.68e-03 | 141 | 198 | 5 | C0005684 | |
| Disease | migraine disorder, Headache | 2.72e-03 | 86 | 198 | 4 | HP_0002315, MONDO_0005277 | |
| Disease | Colorectal Neoplasms | 2.77e-03 | 277 | 198 | 7 | C0009404 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.83e-03 | 12 | 198 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Hematologic Neoplasms | 2.83e-03 | 12 | 198 | 2 | C0376545 | |
| Disease | Congenital muscular dystrophy | 2.83e-03 | 12 | 198 | 2 | cv:C0699743 | |
| Disease | subiculum volume | 3.01e-03 | 43 | 198 | 3 | EFO_0009399 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.30e-03 | 148 | 198 | 5 | C0279702 | |
| Disease | colon carcinoma (is_marker_for) | 3.33e-03 | 13 | 198 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Malignant neoplasm of kidney | 3.43e-03 | 45 | 198 | 3 | C0740457 | |
| Disease | homocysteine measurement | 3.65e-03 | 46 | 198 | 3 | EFO_0004578 | |
| Disease | Diabetic Neuralgia | 3.87e-03 | 14 | 198 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 3.87e-03 | 14 | 198 | 2 | C0011882 | |
| Disease | Fanconi anemia | 3.87e-03 | 14 | 198 | 2 | cv:C0015625 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 3.87e-03 | 14 | 198 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 3.87e-03 | 14 | 198 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 3.87e-03 | 14 | 198 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 3.87e-03 | 14 | 198 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 3.87e-03 | 14 | 198 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 3.87e-03 | 14 | 198 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 3.87e-03 | 14 | 198 | 2 | C0393835 | |
| Disease | Left ventricular noncompaction | 3.87e-03 | 14 | 198 | 2 | C1960469 | |
| Disease | Osteosarcoma | 3.88e-03 | 47 | 198 | 3 | C0029463 | |
| Disease | hippocampal CA1 volume | 4.12e-03 | 48 | 198 | 3 | EFO_0009394 | |
| Disease | cholestasis (biomarker_via_orthology) | 4.37e-03 | 49 | 198 | 3 | DOID:13580 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTIEMVFHAKAVEVY | 186 | Q6ZTR7 | |
| HIEFNSMKVLEEVDF | 151 | Q8NFR7 | |
| EKYVTLLQELERHME | 381 | Q15052 | |
| VTREELYKMLAHEDL | 101 | Q9Y689 | |
| ITKEELYRMLAHEDL | 101 | Q96KC2 | |
| KYVLHMIEDGEIFAS | 336 | Q9UNS2 | |
| LHVIVDEVYMLSVFE | 281 | Q96QU6 | |
| EETKYIELMIVNDHL | 236 | Q9P0K1 | |
| ELDLIFHMDKVHYIL | 106 | P59780 | |
| HLFEELAMDVYDEVD | 276 | Q14161 | |
| KYFAHIIKEVMSDLE | 516 | Q01433 | |
| FKSDETEDLFLNMEH | 701 | Q6UB98 | |
| IDEYVETVDMLKSHI | 391 | Q6ZUJ8 | |
| HSELMEKFLTDYLND | 1571 | Q6W2J9 | |
| LDDDFTAMYKVLDVV | 436 | Q9BXF3 | |
| EMKEFYHIQIRDLED | 36 | Q5JU67 | |
| SIEDISMKFDELYHL | 891 | Q9Y2H0 | |
| LKNEMVELELTEFHY | 86 | Q86XH1 | |
| LTEFEAYKHRVEDMQ | 126 | Q8NB25 | |
| SQIMEYIHKIEADLE | 1501 | Q9NZN5 | |
| EMTHETLYLAVKLVD | 1176 | Q8WWL7 | |
| EHERLFDLIQKMLEY | 446 | P49759 | |
| VDMLNDIYKSFDHIV | 846 | P25092 | |
| AYLVAHKLMSFEDVL | 961 | P08183 | |
| LVETLNHEMYEAKYV | 246 | P27338 | |
| VKDDDLFHSYTTIMA | 381 | Q8NEZ5 | |
| KSVYVVLDLMESDLH | 131 | Q13164 | |
| IIFDYLLDENEDMHS | 146 | Q504Q3 | |
| EMSFFEVYNEKIHDL | 491 | Q15058 | |
| KVAHIMELDVQEYEF | 681 | O95461 | |
| MEIHAYRKLLEGEEE | 371 | P02545 | |
| ELVVHTDIDAAKVYM | 246 | P16435 | |
| MHLELDISDSKIRYE | 301 | P16435 | |
| ASEVDFYIDKDMIHI | 516 | Q9Y262 | |
| FYIDKDMIHIADTKV | 521 | Q9Y262 | |
| VFHIYTDVEDMKEQE | 181 | Q9NYF5 | |
| KLHEVYETDMEIYLI | 416 | Q9C098 | |
| IHSLMEKYSELLQED | 676 | Q8IY21 | |
| LIEDHFDVTVKMSTY | 231 | Q9NZ08 | |
| HVVDEGADEYKVIML | 1751 | A6NKB5 | |
| LTHFYEVDIDQSMLD | 506 | Q92628 | |
| LVVDKETDNMYRLAH | 201 | A8MUH7 | |
| LQESLEHIEMYEKQI | 206 | Q6N069 | |
| FNVDMYEEIHRKLSE | 86 | Q13098 | |
| ENDITHFYMLTIDKD | 1111 | O96028 | |
| HFYMLTIDKDRIIDA | 1116 | O96028 | |
| VEYMLVSFDHENKKV | 51 | P48506 | |
| NHDELMEEKVAFYIR | 2771 | O60229 | |
| LLMYFTKHSDEEVQT | 2176 | Q6KC79 | |
| KETFENLIYSHRMLE | 481 | Q96JB8 | |
| EELAYLRKNHEEEML | 246 | P08779 | |
| HFEEIYATELSETMI | 166 | Q9H1A3 | |
| VELEMTESHTVFIDY | 976 | Q8NG31 | |
| YQLTKLLDSMHEVVE | 716 | P04150 | |
| FNYALVIFEMVHLKE | 116 | P06213 | |
| AHFKEMESIDQYIER | 191 | Q9BXS6 | |
| EAHISDEVFTVLYAM | 266 | Q8NGT2 | |
| YTLDEHLEIDAAMLT | 856 | Q13219 | |
| MALQSELHKLYDEET | 2791 | Q9Y4D8 | |
| DIHFDMNLTYEKEAE | 296 | Q9UKS7 | |
| EDKFYSLDELHILDM | 716 | Q86Y13 | |
| EDSEKILAAYRVFME | 281 | O95672 | |
| DHSYQEEAAMELKVE | 131 | Q16653 | |
| IAYHLLEDYEMAAKI | 156 | Q9BXJ9 | |
| KESFEAEGHLYIVME | 66 | P51956 | |
| IDKHIAELIFYMEEL | 401 | Q9Y2A7 | |
| FTEYLMVDEEAHEFV | 371 | Q16827 | |
| NFDIKHDLDLMVDTY | 726 | O43422 | |
| KTLDFEEMTEYELLI | 2406 | Q6V1P9 | |
| KHEDVEEVYVYLMHN | 171 | Q9BXJ4 | |
| LEEIMKYEASILTHD | 116 | P02679 | |
| HIYEGFDKVLLEMNT | 456 | A4FU69 | |
| DLEHYMLVLKENEDH | 256 | Q9NWS6 | |
| LEDFMASHLDYLVLE | 1206 | Q13315 | |
| FVVEHDFIMATYLAD | 516 | P61221 | |
| QEVYAEIMAVLKHDD | 1546 | Q13535 | |
| DVEQHTLAKYLMELT | 316 | P14635 | |
| KDMAYEHLIDDLLAA | 986 | B1AJZ9 | |
| EHLYVMVNAKFEEES | 76 | P54105 | |
| AYISLVEEEDQHMKL | 31 | Q9P2N7 | |
| KMHYEILIHDLQEEI | 86 | P15088 | |
| ETYLHIMKNEEEVVI | 206 | Q9BXJ1 | |
| AKQYFLLADMIVEEE | 986 | Q9P2K1 | |
| RILEFDYEMKLLNHV | 196 | Q9BVC3 | |
| MDVHYSEEVLLELLE | 1686 | Q5JSL3 | |
| DHIQEAMRALEYLFK | 721 | Q8IZD9 | |
| IETAQEDFEEHMIKY | 111 | Q5T0U0 | |
| KETLTFVFEYMHTDL | 171 | Q96Q40 | |
| DLKQLTVVMEHYLEE | 2381 | Q8TD57 | |
| MSEEELQLHFTYEEK | 121 | Q7RTS9 | |
| LMAEEAAVFAKYLAH | 196 | A5D6W6 | |
| DFIDSFLIHMQEEEK | 266 | P20853 | |
| LLTKYSVIMLDEAHE | 166 | Q9H5Z1 | |
| EAFLHVAVDMYLKLV | 1351 | O15360 | |
| DFSQISILKELYEHM | 146 | Q8NBF6 | |
| YMKTIADLELHYQEF | 576 | P15924 | |
| EEDFRMYHEILGQVK | 686 | Q8IYE1 | |
| DDTYEELHLIVYKAM | 306 | P86791 | |
| DDTYEELHLIVYKAM | 306 | P86790 | |
| FLTGYEVKVMEDAHL | 546 | Q8NI60 | |
| KYLERFLETAEQHFM | 116 | U3KPV4 | |
| TEVTATEEHVDKMYL | 431 | Q5TB80 | |
| HTLMDKEEEELLFFF | 596 | Q494V2 | |
| HMYEDVALIKDHTLV | 1246 | Q6IQ26 | |
| IIHDFEKGMTAYLDL | 141 | O43736 | |
| IMIAIVHSDYLTFED | 96 | P41968 | |
| DFEQDILEDMYHAIK | 866 | Q92538 | |
| ILEDMYHAIKNEEIV | 871 | Q92538 | |
| EMILQASEYEDLEHK | 146 | Q7Z4H3 | |
| LMTSKEDIRDNVIHY | 646 | P55289 | |
| AEKEELMLVHSLEYI | 136 | Q9UBN7 | |
| HGSDVYLLRKMVEEV | 121 | Q9UHL9 | |
| EDFDQRVMEHFIKLY | 256 | P11021 | |
| YIEEKELDAFFLHML | 31 | O76038 | |
| DEDEDYIVDHTIIMY | 251 | O75880 | |
| LYIHFSEDLTLFDEM | 786 | Q9NZJ4 | |
| AEKLVENDFEALLMY | 3376 | Q9NZJ4 | |
| FFLMYLINKDETEHT | 4991 | P21817 | |
| FLMYLINKDETEHTG | 4921 | Q92736 | |
| HEFEYEIQFESEAMK | 2956 | Q6ZTR5 | |
| IMDYESLEKANHEEV | 246 | P00491 | |
| VSLAYEKAESDIMHL | 831 | P20648 | |
| SEKDIVHSALAYTME | 501 | P49448 | |
| DAMEYHTKIRELILD | 146 | Q8N3J2 | |
| SKFAMHYIIEEIDED | 281 | Q9UBU6 | |
| EHKVFDLVMLFIIYS | 376 | Q9BXW9 | |
| TLAHFEDYKSVEMVA | 826 | Q5VU65 | |
| EKYMLTHQELASDGE | 856 | Q02241 | |
| MLENYTHIHKEELEL | 66 | O14829 | |
| LTSIYFLMHEEVIED | 151 | Q15743 | |
| SMKLDYRHQDEAVVL | 1871 | P11717 | |
| YMIFDHEFTKLVKEL | 606 | O60763 | |
| IRFNIDYTIHFIEEM | 621 | Q9NRR4 | |
| DKVFEVMLATDRSHY | 26 | P22061 | |
| DHFETIMKYAEKLIQ | 271 | P07814 | |
| EMKFEVENLILHKDY | 251 | P00749 | |
| AVLHAIYKEMTEDLF | 1271 | Q96KN7 | |
| HSLMKSDLVEYFTLE | 376 | Q9H5Y7 | |
| TEYMELLAAEKHQVE | 151 | Q6UWJ1 | |
| EEIVKDHLMYLDAVH | 2836 | Q8NF91 | |
| KEYFQGLESHMILTE | 6631 | Q8NF91 | |
| FDITHLVADFMKLEE | 606 | Q8N3T6 | |
| LVKSHLMYAVREEVE | 696 | O75157 | |
| DVEIELKRAHVDMYV | 196 | Q86TJ2 | |
| MQASEDLLKEHYVDL | 41 | P15531 | |
| QHVGLAVDMDEIEKY | 1886 | Q6P3W6 | |
| HVGLAVDMDEIEKYQ | 2131 | Q6P3W6 | |
| QHVGLAVDMDEIEKY | 3106 | Q6P3W6 | |
| HVGLAVDMDEIEKYQ | 3351 | Q6P3W6 | |
| LSYQLMEDHDIDVKT | 651 | Q9H0K6 | |
| LDFKEYVIALHMTTA | 81 | P35243 | |
| KDLHEEMNYITAIIE | 146 | P49354 | |
| LEQHMVIHTEEREYK | 296 | Q9HAZ2 | |
| EEKTILHVKEMYDYQ | 236 | O60508 | |
| AKEEFQEMLFEHSEL | 486 | Q13017 | |
| QEMLFEHSELFYDLD | 491 | Q13017 | |
| VKSHLMYAVREEVEV | 991 | Q15714 | |
| ATIMTDEIFHDVAYK | 361 | Q2Y0W8 | |
| IFEERAHILYMSLEK | 101 | Q9NUC0 | |
| FDYIMKHEEGLNEDL | 101 | Q9NRH2 | |
| DLISHNEMFSDIYKI | 6 | Q9HAU6 | |
| EMDDLKLYLETHLSF | 811 | Q13023 | |
| FTDVEDHMFIAKEES | 791 | O75891 | |
| LVDFVIHFMEEIDKE | 131 | P59998 | |
| AEEHEILTKSYMELL | 721 | Q8TCG1 | |
| IIVHKFDFSDEEIMA | 126 | Q2KHT3 | |
| HELSMKDELLQFYTS | 166 | Q9UPV9 | |
| FKEVGIEFMDLYSHL | 891 | Q6P2Q9 | |
| LSYMVSLEVEEEKHR | 181 | A6NKD2 | |
| VYHENDTIAKYEIMD | 221 | Q4G0F5 | |
| HLDYVDTERIMTEKL | 466 | O14980 | |
| HYSMKENLETFEEVV | 206 | Q92574 | |
| TVDNKMLDDLYEDIH | 526 | Q9C0E2 | |
| VMEHVYEKIINLDNE | 596 | Q8TAF3 | |
| FDLRAAIVYHTKEME | 656 | Q7Z417 | |
| QELKDTDLDYLEMFV | 281 | Q9ULX5 | |
| TDLDYLEMFVHVAEV | 286 | Q9ULX5 | |
| VLDHAMEAERLVEKY | 296 | O15020 | |
| VLFLKYEDMHRDLVT | 191 | Q9BR01 | |
| MNSELDYYEKFEEVH | 1 | P49888 | |
| FEEVHGILMYKDFVK | 11 | P49888 | |
| KYERELMLHAADVEA | 1081 | P12270 | |
| IHFFLALYLASDMEE | 156 | A6NLX3 | |
| VFDVESRELEKDMHY | 91 | Q7L523 | |
| AMEEALILDNKYTEH | 2271 | Q13813 | |
| SYKEVMKIEIHFDLQ | 376 | Q5T4T6 | |
| THEDYMEGILEVQAK | 416 | P17980 | |
| VLMVETHNEIYDKFK | 111 | P01137 | |
| ELLFLHVYEFDEVMF | 131 | Q9NPG8 | |
| IATLMTDEVFHDVAY | 391 | Q6U841 | |
| DLISHDEMFSDIYKI | 6 | P13693 | |
| EKNSLIYELFSVMVH | 481 | Q96K76 | |
| TLMIENIDYKHSFER | 256 | Q6P2S7 | |
| AFSKLIIYDIVDMHA | 871 | Q8WVM7 | |
| IIYDIVDMHAAADIF | 876 | Q8WVM7 | |
| AVDLTMELYQHLESK | 356 | Q9NPH0 | |
| YVFDVESRELEKDMH | 151 | Q5VZM2 | |
| LHMFLQDEIIDKSYT | 141 | O60493 | |
| QMSEVEALSVELKHY | 666 | Q96RU2 | |
| FYLSHQRLMDEKVDV | 971 | Q9NYK1 | |
| ALNDLDDYEKHFTVM | 501 | Q14166 | |
| HVKMTDDELVYNIHL | 171 | P62906 | |
| SYLEYQKVMREIEHL | 216 | O95347 | |
| VEVLFIDTDYHFDML | 76 | O43543 | |
| FFYMHKEIFDELLET | 946 | Q86T82 | |
| AETIEKLYVHMEDAH | 311 | Q9NRM2 | |
| KLYVHMEDAHEFDLL | 316 | Q9NRM2 | |
| TLMSDEVFHDIAYKA | 346 | Q9Y6R1 | |
| QYSLLKEHEVEKMFT | 51 | Q96AX1 | |
| QEHSYLEKGMLASEE | 806 | Q9C0G0 | |
| DEIATYMVEHDFILQ | 1226 | Q9Y3S1 | |
| SYEEVRKEHEILMQL | 281 | Q2TAA8 | |
| MEYLAEQKFVHRDLA | 1196 | Q04912 | |
| FMFQDEIEDFLRKHI | 476 | O94874 | |
| MLVTHDYTAVKEDEI | 2556 | O75962 | |
| FEEEQSHGMKLERYI | 151 | Q8WXB4 | |
| IAEVRMHYEEIALKS | 311 | Q7RTS7 | |
| IKMFYEEHLHLDDEI | 81 | Q9BV57 |